STOCK TITAN

D-Wave Quantum Q3 2026 loss narrows to $48.2M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

D-Wave Quantum Inc. (QBTS) reported third-quarter 2026 revenue of $4.513 million, compared with $3.739 million a year earlier, and a net loss of $48.197 million versus $139.986 million. For the first nine months, revenue was $10.447 million versus $21.835 million, net loss was $114.582 million versus $312.736 million, and operating cash used was $109.025 million versus $53.610 million.

D-Wave completed its acquisition of Quantum Circuits on January 20, 2026, for $538.508 million in consideration, including $256.030 million cash and $282.039 million equity consideration. The acquisition was intended to enhance gate-model capabilities with Quantum Circuits’ dual-rail qubit technology. The preliminary purchase allocation included $217.150 million in intangible assets and $342.588 million in goodwill.

The U.S. Department of Commerce agreed to provide up to $100.0 million in milestone-based award tranches. D-Wave issued 7,095,721 shares at $14.093 per share under the related agreement; no cash was exchanged at closing, and no award funds had been received as of September 30, 2026. Cash and cash equivalents were $279.366 million as of that date.

3 points · 1 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 2 points

How the balance works

Positive

  • Major pointQuantum Circuits acquisition: $538.508 million consideration for gate-model technology. 16% of market cap
  • Moderate pointThird-quarter revenue was $4.513 million, versus $3.739 million a year earlier.
  • Moderate pointThird-quarter net loss was $48.197 million, versus $139.986 million in 2025.

Negative

  • Moderate pointNine-month revenue fell to $10.447 million from $21.835 million.
  • Moderate pointOperating cash used increased to $109.025 million, versus $53.610 million in 2025.

Filing Explained

Milestone decisions govern the remaining award, while D-Wave’s repurchase option applies only if the Department terminates before the Award Period ends.

Under the CHIPS Act award, D-Wave issued 7,095,721 shares to the Department of Commerce on September 8, 2026; no award funds had been received by September 30, 2026, so the share issuance—and its reduction of existing holders’ percentage ownership—was already in effect.

Of the $100 million award, $53.6 million became available at the award date; the remaining $46.4 million depends on milestone determinations by the Department, which has sole discretion over them. Funds drawn must be applied to eligible project costs within 30 days or returned.

While held by a U.S. government entity, the shares generally cannot be voted except on specified matters affecting share rights or a business combination. Transfers are limited to shares corresponding to award funds drawn, net of amounts returned, and are subject to additional restrictions.

If the Department terminates the agreement for convenience before the Award Period ends, D-Wave may elect to repurchase for $1 in total a number of shares tied to award funds not received or returned; the election window is 120 to 150 days after the Award Period ends.

Third-quarter revenue $4.513 million Three months ended September 30, 2026; $3.739 million in 2025
Third-quarter net loss ($48.197 million) Three months ended September 30, 2026; net loss was $139.986 million in 2025
Nine-month revenue $10.447 million Nine months ended September 30, 2026; $21.835 million in 2025
Nine-month net loss ($114.582 million) Nine months ended September 30, 2026; net loss was $312.736 million in 2025
Cash used in operating activities $109.025 million Nine months ended September 30, 2026; $53.610 million in 2025
Quantum Circuits acquisition consideration $538.508 million Acquisition completed January 20, 2026
U.S. Department of Commerce award Up to $100.0 million Disbursed in tranches subject to specified milestones
Shares issued to the Department of Commerce 7,095,721 shares Issued at $14.093 per share under the related agreement
dual-rail qubit technology technical
"Quantum Circuits’ dual-rail qubit technology"
remaining performance obligations financial
"aggregate amount of remaining performance obligations"
Remaining performance obligations are the work a company still needs to complete for its customers, like finishing a service or delivering a product. It’s important because it shows how much future income the company has coming in from current agreements, giving a clearer picture of its ongoing business.
contra-equity financial
"classified as contra-equity"
relief-from-royalty method financial
"using the relief-from-royalty method"
available-for-sale debt securities financial
"available-for-sale debt securities"
A type of debt investment—like bonds or loans a company buys—that the company intends to hold for a while but may sell before it matures. Think of it as lending money with the option to sell the IOU; changes in its market value alter the company’s reported net worth now but usually don’t affect reported profit until the investment is actually sold, so investors watch these holdings for balance-sheet risk and potential future gains or losses.
revenue-based formula financial
"determined using a revenue-based formula"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much of QBTS’s Commerce award was available at the award date?

$53.6 million became available at the Award Date, while the remaining $46.4 million was subject to milestone-achievement determinations made by the Department in its sole discretion. Funds drawn from the Award Date tranche or a later tranche had to be applied to eligible project costs within 30 days or returned.

What were QBTS’s remaining performance obligations?

As of September 30, 2026, unsatisfied or partially unsatisfied customer-contract performance obligations totaled $38.3 million. D-Wave expected approximately 59% to be recognized as revenue over the next 12 months and 71% over the next two years, with the remainder thereafter.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001907982December 312026Q3falseP5D456xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureqbts:facilityiso4217:CADqbts:assetqbts:customerqbts:trancheqbts:installmentutr:Rateqbts:voteqbts:segment00019079822026-01-012026-09-3000019079822026-11-1300019079822026-09-3000019079822025-12-3100019079822026-07-012026-09-3000019079822025-07-012025-09-3000019079822025-01-012025-09-300001907982us-gaap:CommonStockMember2026-06-300001907982us-gaap:AdditionalPaidInCapitalMember2026-06-300001907982us-gaap:RetainedEarningsMember2026-06-300001907982us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-06-3000019079822026-06-300001907982us-gaap:CommonStockMember2026-07-012026-09-300001907982us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-300001907982us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-07-012026-09-300001907982us-gaap:RetainedEarningsMember2026-07-012026-09-300001907982us-gaap:CommonStockMember2026-09-300001907982us-gaap:AdditionalPaidInCapitalMember2026-09-300001907982us-gaap:RetainedEarningsMember2026-09-300001907982us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-09-300001907982us-gaap:CommonStockMember2025-06-300001907982us-gaap:AdditionalPaidInCapitalMember2025-06-300001907982us-gaap:RetainedEarningsMember2025-06-300001907982us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-3000019079822025-06-300001907982us-gaap:CommonStockMember2025-07-012025-09-300001907982us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-300001907982us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-300001907982us-gaap:RetainedEarningsMember2025-07-012025-09-300001907982us-gaap:CommonStockMember2025-09-300001907982us-gaap:AdditionalPaidInCapitalMember2025-09-300001907982us-gaap:RetainedEarningsMember2025-09-300001907982us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-3000019079822025-09-300001907982us-gaap:CommonStockMember2025-12-310001907982us-gaap:AdditionalPaidInCapitalMember2025-12-310001907982us-gaap:RetainedEarningsMember2025-12-310001907982us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001907982us-gaap:CommonStockMember2026-01-012026-09-300001907982us-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-300001907982us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-09-300001907982us-gaap:RetainedEarningsMember2026-01-012026-09-300001907982us-gaap:CommonStockMember2024-12-310001907982us-gaap:AdditionalPaidInCapitalMember2024-12-310001907982us-gaap:RetainedEarningsMember2024-12-310001907982us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-3100019079822024-12-310001907982qbts:LincolnParkPurchaseAgreementMemberus-gaap:CommonStockMember2025-01-012025-09-300001907982qbts:LincolnParkPurchaseAgreementMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-300001907982qbts:LincolnParkPurchaseAgreementMember2025-01-012025-09-300001907982qbts:AtTheMarketOfferingMemberus-gaap:CommonStockMember2025-01-012025-09-300001907982qbts:AtTheMarketOfferingMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-300001907982qbts:AtTheMarketOfferingMember2025-01-012025-09-300001907982us-gaap:CommonStockMember2025-01-012025-09-300001907982us-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-300001907982us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-09-300001907982us-gaap:RetainedEarningsMember2025-01-012025-09-300001907982us-gaap:DevelopedTechnologyRightsMember2026-09-300001907982us-gaap:TrademarksMember2026-09-300001907982us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2026-09-300001907982qbts:SIFLoanMember2020-11-200001907982us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2026-09-300001907982us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel2Member2026-09-3000019079822026-09-040001907982us-gaap:PrivatePlacementMember2026-09-082026-09-080001907982us-gaap:PrivatePlacementMember2026-09-080001907982us-gaap:PrivatePlacementMember2026-09-302026-09-300001907982qbts:QuantumCircuitsInc.Member2025-01-012026-09-300001907982qbts:QuantumCircuitsInc.Member2025-01-012025-12-310001907982qbts:QuantumCircuitsInc.Member2026-01-202026-01-200001907982qbts:QuantumCircuitsInc.Member2026-01-2000019079822026-01-200001907982qbts:QuantumCircuitsInc.Memberus-gaap:DevelopedTechnologyRightsMember2026-01-202026-01-200001907982qbts:QuantumCircuitsInc.Memberus-gaap:TrademarksMember2026-01-202026-01-200001907982qbts:QuantumCircuitsInc.Memberus-gaap:DevelopedTechnologyRightsMember2026-01-200001907982qbts:QuantumCircuitsInc.Memberus-gaap:TrademarksMember2026-01-200001907982qbts:QuantumCircuitsInc.Member2026-01-012026-09-300001907982qbts:QuantumCircuitsInc.Member2025-01-012025-09-300001907982qbts:QuantumCircuitsInc.Member2026-07-012026-09-300001907982qbts:QuantumCircuitsInc.Member2025-07-012025-09-300001907982qbts:QuantumCircuitsInc.Member2026-01-202026-09-300001907982qbts:SystemSalesMember2026-07-012026-09-300001907982qbts:SystemSalesMember2025-07-012025-09-300001907982qbts:SystemSalesMember2026-01-012026-09-300001907982qbts:SystemSalesMember2025-01-012025-09-300001907982qbts:QCaaSMember2026-07-012026-09-300001907982qbts:QCaaSMember2025-07-012025-09-300001907982qbts:QCaaSMember2026-01-012026-09-300001907982qbts:QCaaSMember2025-01-012025-09-300001907982qbts:ProfessionalServicesMember2026-07-012026-09-300001907982qbts:ProfessionalServicesMember2025-07-012025-09-300001907982qbts:ProfessionalServicesMember2026-01-012026-09-300001907982qbts:ProfessionalServicesMember2025-01-012025-09-300001907982us-gaap:ProductAndServiceOtherMember2026-07-012026-09-300001907982us-gaap:ProductAndServiceOtherMember2025-07-012025-09-300001907982us-gaap:ProductAndServiceOtherMember2026-01-012026-09-300001907982us-gaap:ProductAndServiceOtherMember2025-01-012025-09-300001907982us-gaap:TransferredOverTimeMember2026-07-012026-09-300001907982us-gaap:TransferredOverTimeMember2025-07-012025-09-300001907982us-gaap:TransferredOverTimeMember2026-01-012026-09-300001907982us-gaap:TransferredOverTimeMember2025-01-012025-09-300001907982us-gaap:TransferredAtPointInTimeMember2026-07-012026-09-300001907982us-gaap:TransferredAtPointInTimeMember2025-07-012025-09-300001907982us-gaap:TransferredAtPointInTimeMember2026-01-012026-09-300001907982us-gaap:TransferredAtPointInTimeMember2025-01-012025-09-300001907982country:US2026-07-012026-09-300001907982country:US2025-07-012025-09-300001907982country:US2026-01-012026-09-300001907982country:US2025-01-012025-09-300001907982country:JP2026-07-012026-09-300001907982country:JP2025-07-012025-09-300001907982country:JP2026-01-012026-09-300001907982country:JP2025-01-012025-09-300001907982country:DE2026-07-012026-09-300001907982country:DE2025-07-012025-09-300001907982country:DE2026-01-012026-09-300001907982country:DE2025-01-012025-09-300001907982country:CA2026-07-012026-09-300001907982country:CA2025-07-012025-09-300001907982country:CA2026-01-012026-09-300001907982country:CA2025-01-012025-09-300001907982qbts:OtherGeographicalAreasMember2026-07-012026-09-300001907982qbts:OtherGeographicalAreasMember2025-07-012025-09-300001907982qbts:OtherGeographicalAreasMember2026-01-012026-09-300001907982qbts:OtherGeographicalAreasMember2025-01-012025-09-300001907982us-gaap:CustomerConcentrationRiskMemberqbts:CustomerAMemberus-gaap:RevenueFromContractWithCustomerMember2026-07-012026-09-300001907982us-gaap:CustomerConcentrationRiskMemberqbts:CustomerAMemberus-gaap:RevenueFromContractWithCustomerMember2025-07-012025-09-300001907982us-gaap:CustomerConcentrationRiskMemberqbts:CustomerAMemberus-gaap:RevenueFromContractWithCustomerMember2026-01-012026-09-300001907982us-gaap:CustomerConcentrationRiskMemberqbts:CustomerAMemberus-gaap:RevenueFromContractWithCustomerMember2025-01-012025-09-300001907982us-gaap:CustomerConcentrationRiskMemberqbts:CustomerBMemberus-gaap:RevenueFromContractWithCustomerMember2026-07-012026-09-300001907982us-gaap:CustomerConcentrationRiskMemberqbts:CustomerBMemberus-gaap:RevenueFromContractWithCustomerMember2025-07-012025-09-300001907982us-gaap:CustomerConcentrationRiskMemberqbts:CustomerBMemberus-gaap:RevenueFromContractWithCustomerMember2026-01-012026-09-300001907982us-gaap:CustomerConcentrationRiskMemberqbts:CustomerBMemberus-gaap:RevenueFromContractWithCustomerMember2025-01-012025-09-300001907982us-gaap:CustomerConcentrationRiskMemberqbts:CustomerCMemberus-gaap:RevenueFromContractWithCustomerMember2026-07-012026-09-300001907982us-gaap:CustomerConcentrationRiskMemberqbts:CustomerCMemberus-gaap:RevenueFromContractWithCustomerMember2025-07-012025-09-300001907982us-gaap:CustomerConcentrationRiskMemberqbts:CustomerCMemberus-gaap:RevenueFromContractWithCustomerMember2026-01-012026-09-300001907982us-gaap:CustomerConcentrationRiskMemberqbts:CustomerCMemberus-gaap:RevenueFromContractWithCustomerMember2025-01-012025-09-3000019079822026-10-012026-09-3000019079822027-10-012026-09-300001907982us-gaap:USGovernmentAgenciesDebtSecuritiesMember2026-09-300001907982us-gaap:BankTimeDepositsMember2026-09-300001907982us-gaap:USGovernmentAgenciesDebtSecuritiesMember2025-12-310001907982us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2026-09-300001907982us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2025-12-310001907982qbts:LabEquipmentMember2026-09-300001907982qbts:LabEquipmentMember2025-12-310001907982us-gaap:ComputerEquipmentMember2026-09-300001907982us-gaap:ComputerEquipmentMember2025-12-310001907982us-gaap:LeaseholdImprovementsMember2026-09-300001907982us-gaap:LeaseholdImprovementsMember2025-12-310001907982us-gaap:FurnitureAndFixturesMember2026-09-300001907982us-gaap:FurnitureAndFixturesMember2025-12-310001907982us-gaap:ConstructionInProgressMember2026-09-300001907982us-gaap:ConstructionInProgressMember2025-12-310001907982us-gaap:DevelopedTechnologyRightsMember2026-09-300001907982us-gaap:DevelopedTechnologyRightsMember2025-12-310001907982us-gaap:TrademarksMember2026-09-300001907982us-gaap:TrademarksMember2025-12-310001907982us-gaap:SoftwarePurchasedMember2026-09-300001907982us-gaap:SoftwarePurchasedMember2025-12-310001907982us-gaap:SoftwareDevelopmentMember2026-09-300001907982us-gaap:SoftwareDevelopmentMember2025-12-310001907982us-gaap:OtherIntangibleAssetsMember2026-09-300001907982us-gaap:OtherIntangibleAssetsMember2025-12-310001907982srt:MinimumMember2026-09-300001907982srt:MaximumMember2026-09-300001907982us-gaap:NotesPayableOtherPayablesMemberqbts:EquipmentFinancingTermLoanMember2026-09-300001907982us-gaap:NotesPayableOtherPayablesMemberqbts:EquipmentFinancingTermLoanMember2025-12-310001907982us-gaap:NotesPayableOtherPayablesMemberqbts:SIFLoanMember2026-09-300001907982us-gaap:NotesPayableOtherPayablesMemberqbts:SIFLoanMember2025-12-310001907982qbts:SIFLoanMember2023-12-310001907982qbts:SIFLoanMember2020-11-202020-11-200001907982qbts:SIFLoanMember2026-09-300001907982qbts:SIFLoanMember2025-12-310001907982qbts:SIFLoanMemberus-gaap:FairValueInputsLevel2Member2026-09-300001907982qbts:EquipmentFinancingAgreementMemberqbts:TrinityCapitalIncMember2025-08-012025-08-010001907982qbts:EquipmentFinancingAgreementMemberqbts:TrinityCapitalIncMember2026-09-022026-09-020001907982qbts:EquipmentFinancingAgreementMemberqbts:TrinityCapitalIncMember2025-08-0100019079822025-08-012025-08-0100019079822025-08-010001907982qbts:EndOfTermPaymentMember2026-09-300001907982qbts:EquipmentFinancingAgreementMemberqbts:TrinityCapitalIncMember2026-01-012026-09-300001907982qbts:EquipmentFinancingAgreementMemberqbts:TrinityCapitalIncMember2026-09-300001907982qbts:EquipmentFinancingAgreementMemberqbts:TrinityCapitalIncMemberus-gaap:FairValueInputsLevel2Member2026-09-300001907982us-gaap:NotesPayableOtherPayablesMemberqbts:TPCGovernmentLoansMember2010-01-012021-12-310001907982us-gaap:NotesPayableOtherPayablesMemberqbts:TPCGovernmentLoansMember2020-11-230001907982qbts:PublicWarrantsMember2022-08-052022-08-050001907982qbts:PrivateWarrantsMember2022-08-052022-08-0500019079822025-01-012025-12-3100019079822025-11-190001907982qbts:PublicWarrantsMember2026-09-300001907982qbts:PrivateWarrantsMember2026-09-300001907982qbts:PreferredStockWarrantsMember2020-11-300001907982qbts:PreferredStockWarrantsMember2022-08-0500019079822022-08-050001907982qbts:PreferredStockWarrantsMember2022-11-2800019079822022-11-280001907982qbts:PreferredStockWarrantsMember2026-09-300001907982srt:MinimumMember2022-08-052022-08-050001907982srt:MaximumMember2022-08-052022-08-0500019079822022-08-052022-08-050001907982us-gaap:RestrictedStockUnitsRSUMember2025-12-310001907982us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-09-300001907982us-gaap:RestrictedStockUnitsRSUMember2026-09-300001907982us-gaap:CostOfRevenue2026-07-012026-09-300001907982us-gaap:CostOfRevenue2025-07-012025-09-300001907982us-gaap:CostOfRevenue2026-01-012026-09-300001907982us-gaap:CostOfRevenue2025-01-012025-09-300001907982us-gaap:ResearchAndDevelopmentExpense2026-07-012026-09-300001907982us-gaap:ResearchAndDevelopmentExpense2025-07-012025-09-300001907982us-gaap:ResearchAndDevelopmentExpense2026-01-012026-09-300001907982us-gaap:ResearchAndDevelopmentExpense2025-01-012025-09-300001907982us-gaap:GeneralAndAdministrativeExpense2026-07-012026-09-300001907982us-gaap:GeneralAndAdministrativeExpense2025-07-012025-09-300001907982us-gaap:GeneralAndAdministrativeExpense2026-01-012026-09-300001907982us-gaap:GeneralAndAdministrativeExpense2025-01-012025-09-300001907982us-gaap:SellingAndMarketingExpense2026-07-012026-09-300001907982us-gaap:SellingAndMarketingExpense2025-07-012025-09-300001907982us-gaap:SellingAndMarketingExpense2026-01-012026-09-300001907982us-gaap:SellingAndMarketingExpense2025-01-012025-09-300001907982qbts:PublicWarrantsMemberus-gaap:WarrantMember2026-01-012026-09-300001907982qbts:PublicWarrantsMemberus-gaap:WarrantMember2025-01-012025-09-300001907982qbts:CommonShareWarrantsMemberus-gaap:WarrantMember2026-01-012026-09-300001907982qbts:CommonShareWarrantsMemberus-gaap:WarrantMember2025-01-012025-09-300001907982qbts:EquipmentFinancingAgreementWarrantMemberus-gaap:WarrantMember2026-01-012026-09-300001907982qbts:EquipmentFinancingAgreementWarrantMemberus-gaap:WarrantMember2025-01-012025-09-300001907982us-gaap:EmployeeStockOptionMember2026-01-012026-09-300001907982us-gaap:EmployeeStockOptionMember2025-01-012025-09-300001907982us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-09-300001907982us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-09-300001907982us-gaap:PreferredStockMember2026-09-300001907982qbts:A150MATMAgreementMember2025-01-100001907982qbts:A150MATMAgreementMember2025-01-012025-03-310001907982qbts:A150MATMAgreementMember2026-09-300001907982qbts:A400MATMAgreementMember2025-06-100001907982qbts:A400MATMAgreementMember2025-04-012025-06-300001907982qbts:A400MATMAgreementMember2026-09-300001907982qbts:TheATMAgreementMember2026-01-012026-09-3000019079822026-09-080001907982srt:MinimumMember2026-09-080001907982srt:MaximumMember2026-09-080001907982qbts:ExchangeableSharesMember2026-09-300001907982qbts:CommonSharesMember2026-09-300001907982country:CA2026-09-300001907982country:CA2025-12-310001907982country:US2026-09-300001907982country:US2025-12-310001907982qbts:OtherGeographicalAreasMember2026-09-300001907982qbts:OtherGeographicalAreasMember2025-12-310001907982qbts:SophieAmesMember2026-07-012026-09-300001907982qbts:SophieAmesMember2026-09-30
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________
FORM 10-Q
________________________
(Mark One)
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2026
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________ and ____________

Commission File Number: 001-41468

________________________
D-WAVE QUANTUM INC.
(Exact name of registrant as specified in its charter)
________________________
Delaware
88-1068854
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
2650 East Bayshore Road, Palo Alto, California
94303
(Address of Principal Executive Offices)
(Zip Code)
(650) 285-2881
(Registrant's telephone number, including area code)
________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.0001 per shareQBTSThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No  ☐ 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer☐
Accelerated filer
 ☐
Non-accelerated filer☒
Smaller reporting company
 ☐
Emerging growth company
 ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No ☒ 

APPLICABLE ONLY TO CORPORATE ISSUERS:
As of November 13, 2026, there were 376,886,897 outstanding shares of the registrant’s common stock, par value $0.0001 per share. In addition, there were 3,176,096 exchangeable shares outstanding as of November 13, 2026, which are convertible into shares of common stock on a one for one basis at any time for no consideration.


Table of Contents
Page
Cautionary Note Regarding Forward-Looking Statements2
Part I. Financial Information
3
Item 1.
D-Wave Quantum Inc. Financial Statements (Unaudited)
3
Condensed Consolidated Balance Sheets (Unaudited)
3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
4
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)
5
Condensed Consolidated Statements of Cash Flows (Unaudited)
9
Notes to Condensed Consolidated Financial Statements (Unaudited)
10
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
32
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
41
Item 4.
Controls and Procedures
41
Part II. Other Information
43
Item 1.
Legal Proceedings
43
Item 1A.
Risk Factors
44
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
46
Item 3.
Defaults Upon Senior Securities
46
Item 4.
Mine Safety Disclosures
47
Item 5.
Other Information
47
Item 6.
Exhibits
48
Signatures
49





CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Certain statements in this Quarterly Report on Form 10-Q (this “Report”) may constitute “forward-looking statements” within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Our forward-looking statements include, but are not limited to, statements regarding our and our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future, including statements relating to our ability to help customers realize value from quantum computing, development of annealing and gate-model systems and extension of the capabilities of our hybrid and classical solvers, enterprise-scale adoption of quantum computing, statements relating to our development and commercialization plans, dual-platform roadmap and milestones, ability to satisfy the funding conditions of and to realize the anticipated benefits of the award from the U.S. Department of Commerce, and plans to accelerate the projected time to a scaled, error-corrected gate-model quantum computer, among others. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. In some cases, you can identify forward-looking statements by the following words: “believe,” “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “trend,” “estimate,” “predict,” “project,” “potential,” “seem,” “seek,” “future,” “outlook,” “forecast,” “projection,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. We caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, which are subject to a number of risks. Factors that might cause or contribute to a material difference the risks discussed in the Company’s other filings with the SEC, including in Part I, Item 1A, “Risk Factors” in our most recent Annual Report on Form 10-K, as supplemented and updated by subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K that we have filed or will file with the Securities and Exchange Commission (the “SEC”). You should not place undue reliance on these forward-looking statements in making an investment decision with respect to our securities. These forward-looking statements are not intended to serve as, and must not be relied on as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability regarding future performance, events or circumstances. Many of the factors affecting actual performance, events and circumstances are beyond our control. As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. All forward-looking statements set forth in this Report are qualified by these cautionary statements, and there can be no assurance that the actual results or developments we anticipate will be realized or, even if substantially realized, that they will have the expected consequence to or effects on us or our business or operations. These forward-looking statements are based on information available as of the date of this Report and current expectations, forecasts and assumptions, involve a number of judgments, risks and uncertainties, and are not predictions of actual performance. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

2


Part I - Financial Information
Item 1. Financial Statements

D-Wave Quantum Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
September 30,December 31,
(In thousands, except share and per share data)20262025
Assets
Current assets:
Cash and cash equivalents$279,366 $635,347 
Marketable investment securities223,990 249,134 
Trade accounts receivable, net3,543 1,587 
Inventories6,375 2,776 
Prepaid expenses and other current assets11,196 7,388 
Total current assets524,470 896,232 
Property and equipment, net27,077 7,841 
Operating lease right-of-use assets13,539 6,518 
Intangible assets, net208,422 915 
Goodwill342,588 — 
Other non-current assets, net7,148 4,307 
Total assets$1,123,244 $915,813 
Liabilities and stockholders' equity
Current liabilities:
Trade accounts payable$2,240 $950 
Accrued expenses and other current liabilities18,261 15,838 
Current portion of operating lease liabilities1,451 1,448 
Loans payable, net, current1,946 134 
Deferred revenue, current6,404 2,778 
Total current liabilities30,302 21,148 
Operating lease liabilities, net of current portion13,409 6,050 
Loans payable, net, non-current40,073 35,825 
Deferred revenue, non-current2,188 560 
Total liabilities85,972 63,583 
Commitments and contingencies (Note 12)
Stockholders' equity:
Common stock, par value $0.0001 per share; 675,000,000 shares authorized at both September 30, 2026 and December 31, 2025; 379,681,691 shares and 358,741,605 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively.
38 35 
Additional paid-in capital2,142,897 1,843,218 
Accumulated deficit(1,096,584)(982,002)
Accumulated other comprehensive loss(9,079)(9,021)
Total stockholders' equity1,037,272 852,230 
Total liabilities and stockholders’ equity$1,123,244 $915,813 
    
The accompanying notes are an integral part of these condensed consolidated financial statements.

3


D-Wave Quantum Inc.
Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited)

Three Months Ended September 30,Nine Months Ended September 30,
(In thousands, except share and per share data)2026202520262025
Revenue$4,513 $3,739 $10,447 $21,835 
Cost of revenue2,127 1,070 4,539 3,313 
Total gross profit2,386 2,669 5,908 18,522 
Operating expenses:
Research and development31,543 14,075 85,575 37,057 
General and administrative13,100 9,383 48,763 26,491 
Sales and marketing11,225 6,947 33,057 20,503 
Total operating expenses55,868 30,405 167,395 84,051 
Loss from operations(53,482)(27,736)(161,487)(65,529)
Other income (expense), net:
Interest income4,864 8,581 15,677 15,991 
Interest expense(350)(201)(864)(633)
Gain on investment in marketable securities, net882 850 2,762 850 
Change in fair value of warrant liabilities— (121,859)— (259,964)
Other income (expense), net(179)379 818 (3,451)
Total other income (expense), net5,217 (112,250)18,393 (247,207)
Loss before income taxes(48,265)(139,986)(143,094)(312,736)
Income tax benefit (provision), net68 — 28,512 — 
Net loss$(48,197)$(139,986)$(114,582)$(312,736)
Net loss per share, basic and diluted$(0.13)$(0.41)$(0.31)$(1.01)
Weighted-average shares used in computing net loss per share, basic and diluted374,112,327 342,204,831 370,832,873 310,509,005 
Comprehensive loss:
Net loss$(48,197)$(139,986)$(114,582)$(312,736)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment(5)99 153 1,384 
Unrealized losses on available-for-sale securities(35)— (195)— 
Reclassification adjustment for realized gains (losses) included in net income— — (16)— 
Total other comprehensive income (loss), net of tax(40)99 (58)1,384 
Net comprehensive loss$(48,237)$(139,887)$(114,640)$(311,352)



The accompanying notes are an integral part of these condensed consolidated financial statements.

4


D-Wave Quantum Inc.
Condensed Consolidated Statements of Stockholders’ Equity
For the Three Months Ended September 30, 2026
(Unaudited)


Common stockAdditional paid-in capitalAccumulated deficitAccumulated other comprehensive lossTotal stockholders' equity
(In thousands, except share data)SharesAmount
Balances at June 30, 2026372,011,420 $37 $2,140,499 $(1,048,387)$(9,039)$1,083,110 
Issuance of common stock in connection with exercise of stock options and vesting of RSUs574,550 — 162 — — 162 
Issuance of common stock to the U.S. Department of Commerce in connection with the OTA and SIA, net of issuance costs7,095,721 1 (1,147)— — (1,146)
Stock-based compensation— — 10,588 — — 10,588 
Tax withholding related to vesting of restricted stock units— — (7,205)— — (7,205)
Other comprehensive loss— — — — (40)(40)
Net loss— — — (48,197)— (48,197)
Balances at September 30, 2026379,681,691 $38 $2,142,897 $(1,096,584)$(9,079)$1,037,272 



The accompanying notes are an integral part of these condensed consolidated financial statements.

5


D-Wave Quantum Inc.
Condensed Consolidated Statements of Stockholders’ Equity
For the Three Months Ended September 30, 2025
(Unaudited)


Common stockAdditional paid-in capitalAccumulated deficitAccumulated other comprehensive lossTotal stockholders' equity
(In thousands, except share data)SharesAmount
Balances at June 30, 2025339,837,650 $33 $1,503,136 $(799,690)$(9,225)$694,254 
Issuance of common stock in connection with exercise of stock options and vesting of RSUs1,030,091 1 1,366 — — 1,367 
Issuance of common stock in connection with exercise of warrants5,103,454 — 112,544 — — 112,544 
Stock-based compensation— — 6,598 — — 6,598 
Tax withholding related to vesting of restricted stock units— — (4,322)— — (4,322)
Foreign currency translation adjustment, net of tax— — — — 99 99 
Net loss— — — (139,986)— (139,986)
Balances at September 30, 2025345,971,195 $34 $1,619,322 $(939,676)$(9,126)$670,554 



The accompanying notes are an integral part of these condensed consolidated financial statements.

6


D-Wave Quantum Inc.
Condensed Consolidated Statements of Stockholders’ Equity
For the Nine Months Ended September 30, 2026
(Unaudited)


Common stockAdditional paid-in capitalAccumulated deficitAccumulated other comprehensive lossTotal stockholders' equity
(In thousands, except share data)SharesAmount
Balances at December 31, 2025358,741,605 $35 $1,843,218 $(982,002)$(9,021)$852,230 
Equity issued as consideration for acquisition, net10,430,444 2 282,274 — — 282,276 
Issuance of common stock in connection with the Employee Stock Purchase Plan40,686 — 724 — — 724 
Issuance of common stock in connection with exercise of stock options and vesting of RSUs3,373,235 — 1,776 — — 1,776 
Issuance of common stock to the U.S. Department of Commerce in connection with the OTA and SIA, net of issuance costs7,095,721 1 (1,147)— — (1,146)
Stock-based compensation— — 30,142 — — 30,142 
Tax withholding related to vesting of restricted stock units— — (14,090)— — (14,090)
Other comprehensive loss— — — — (58)(58)
Net loss— — — (114,582)— (114,582)
Balances at September 30, 2026379,681,691 $38 $2,142,897 $(1,096,584)$(9,079)$1,037,272 



The accompanying notes are an integral part of these condensed consolidated financial statements.



7


D-Wave Quantum Inc.
Condensed Consolidated Statements of Stockholders’ Equity
For the Nine Months Ended September 30, 2025
(Unaudited)


Common stockAdditional paid-in capitalAccumulated deficitAccumulated other comprehensive lossTotal stockholders' equity
(In thousands, except share data)SharesAmount
Balance at December 31, 2024266,595,867 $27 $700,069 $(626,940)$(10,510)$62,646 
Issuance of common stock in connection with the Lincoln Park Purchase Agreement3,873,113 — 37,787 — — 37,787 
Issuance of common stock in at-the-market offerings, net of issuance costs50,948,852 5 536,736 — — 536,741 
Issuance of common stock in connection with the Employee Stock Purchase Plan95,331 — 291 — — 291 
Issuance of common stock in connection with exercise of stock options and vesting of RSUs6,796,107 1 8,226 — — 8,227 
Issuance of common stock in connection with exercise of warrants17,661,925 1 328,805 328,806 
Stock-based compensation— — 17,394 — — 17,394 
Tax withholding related to vesting of restricted stock units— — (9,986)— — (9,986)
Foreign currency translation adjustment, net of tax— — — — 1,384 1,384 
Net loss— — — (312,736)— (312,736)
Balance at September 30, 2025345,971,195 $34 $1,619,322 $(939,676)$(9,126)$670,554 



The accompanying notes are an integral part of these condensed consolidated financial statements.



8


D-Wave Quantum Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)

Nine Months Ended September 30,
(in thousands)20262025
Cash flows from operating activities:
Net loss$(114,582)$(312,736)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization13,484 1,083 
Deferred income taxes(28,365)— 
Stock-based compensation29,800 17,119 
Amortization of operating right-of-use assets1,089 545 
Provision for excess and obsolete inventory(142)22 
Non-cash interest income416 — 
Non-cash interest expense725 587 
Change in fair value of warrant liabilities— 259,964 
Gain on marketable equity securities(2,762)(850)
Unrealized foreign exchange loss (gain)(1,649)1,275 
Other noncash items— 267 
Change in operating assets and liabilities:
Trade accounts receivable(1,947)(539)
Inventories(7,151)(1,430)
Prepaid expenses and other current assets(2,944)(2,683)
Trade accounts payable(579)203 
Accrued expenses and other current liabilities1,260 607 
Deferred revenue5,254 (15,338)
Operating lease liability(462)(546)
Other non-current assets, net(470)(1,160)
Net cash used in operating activities(109,025)(53,610)
Cash flows from investing activities:
Acquisition of business, net of cash acquired(252,821)— 
Purchase of property and equipment(12,957)(2,203)
Purchases of marketable debt securities(222,692)— 
Maturities of marketable debt securities247,225 — 
Proceeds from recovery of previously written-off convertible note— 959 
Expenditures for internal-use software(649)(323)
Net cash used in investing activities(241,894)(1,567)
Cash flows from financing activities:
Proceeds from the issuance of common stock pursuant to the Lincoln Park Purchase Agreement— 37,787 
Proceeds from the issuance of common stock in at-the-market offerings, net of issuance costs— 536,741 
Proceeds from issuance of common stock upon exercise of warrants— 139,185 
Proceeds from the issuance of common stock upon exercise of stock options1,778 8,227 
Proceeds from common stock issued under the Employee Stock Purchase Plan724 291 
Payment of tax withheld pursuant to stock-based compensation settlements(14,090)(9,986)
Repayments on TPC loan— (365)
Proceeds from equipment financing7,064 412 
Payments for debt issuance costs(50)(248)
Repayment of equipment finance term loan(95)— 
Payments of equity issuance costs(530)— 
Net cash provided by (used in) financing activities(5,199)712,044 
Effect of exchange rate changes on cash and cash equivalents137 1,384 
Net increase (decrease) in cash and cash equivalents(355,981)658,251 
Cash and cash equivalents at beginning of period635,347 177,980 
Cash and cash equivalents at end of period$279,366 $836,231 
Supplemental disclosures of cash flow information:
Cash Paid for Interest$148 $13 
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued for acquisition of business$282,479 $— 
Capitalized stock-based compensation$560 $275 
Inventory applied to capital projects$3,694 $263 
Reclassification of warrant liability to equity upon exercise$— $188,869 
Debt issuance costs related to freestanding warrants$— $338 
Operating lease right-of-use assets exchanged for new operating lease obligations$8,018 $— 
Purchases of property and equipment included in accounts payable$182 $74 
Unrealized gains (losses) on available-for-sale securities included in other comprehensive loss$211 $— 
Warrant exercise proceeds in transit$— $414 
Equity issuance costs in accounts payable$820 $— 



The accompanying notes are an integral part of these condensed consolidated financial statements.

9


D-Wave Quantum Inc.
Notes to Condensed Consolidated Financial Statements
1. DESCRIPTION OF BUSINESS
D-Wave Quantum Inc. (“D-Wave” or the “Company”) was incorporated as a corporation organized and existing under the General Corporation Law of the State of Delaware on January 24, 2022. The Company was formed for the purpose of effecting a merger between DPCM Capital, Inc. (“DPCM”), D-Wave Systems Inc. (“D-Wave Systems”), and certain other affiliated entities through a series of transactions (the “Merger”) pursuant to the definitive agreement entered into on February 7, 2022 (the “Transaction Agreement”). On August 5, 2022, in conjunction with the Merger, DPCM and D-Wave Systems became wholly-owned subsidiaries of, and are operated by, the Company. Upon the completion of the Merger, the Company succeeded to all of the operations of its predecessor, D-Wave Systems.
D-Wave is focused on the development and delivery of quantum computing systems, software, and services. The Company is the world’s first commercial supplier of quantum computers, and the first to offer dual-platform quantum computing products and services, spanning both annealing and gate-model quantum computing technologies. The Company’s superconducting quantum computers provide sub-second response times and can be deployed on-premises or accessed through its LeapTM quantum cloud service (the “Leap service”), which offers 99.9% availability and uptime. Customers apply D-Wave’s technology to address use cases spanning optimization, artificial intelligence, research and more. The Company's current sixth-generation annealing quantum computing system is named Advantage2TM.
We have four operating facilities, which we lease, in North America. These facilities are located in Burnaby, British Columbia, Richmond, British Columbia, Palo Alto, California, and New Haven, Connecticut. In addition, we plan to transition our corporate headquarters from Palo Alto, California to Boca Raton, Florida, and open a key U.S. R&D facility there under a new lease agreement.
2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The unaudited interim condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial reporting and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosure normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to instructions, rules and regulations prescribed by the United States Securities and Exchange Commission (“SEC”). In the opinion of the Company, the unaudited financial information for the interim periods presented reflects all adjustments, which are normal and recurring, necessary for a fair presentation of the condensed consolidated balance sheets, condensed consolidated statements of operations and comprehensive loss, and condensed consolidated statements of cash flows. Interim results should not be regarded as indicative of results that may be expected for any other period or the entire fiscal year.
The interim condensed consolidated financial statements included herein have been prepared on the same basis as the audited annual consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K as of and for the year ended December 31, 2025 filed with the SEC on February 26, 2026.
Principles of Consolidation
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in the condensed consolidated financial statements upon consolidation.

10


Use of estimates
The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s condensed consolidated financial statements and accompanying notes as of the date of the condensed consolidated financial statements. The most significant estimates and assumptions are used in determining: (i) inputs used to recognize revenue over time relating to costs estimated to complete the remaining performance obligations, (ii) standalone selling prices, (iii) fair value of financial instruments, (iv) long term revenue forecasts used in the accounting for the SIF Loan (see below and Note 9 for further information), (v) fair value of assets and liabilities acquired in business combinations, and (vi) asset impairment testing, including long-lived, intangible assets, and goodwill (tested at the reporting unit level). These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience.
The Company’s accounting estimates and assumptions may change over time in response to risks and uncertainties, including uncertainty in the current economic environment due to inflation, tariffs, changes in interest rates and monetary policy, various geopolitical conflicts, and any evolutions thereof. The change could be material in future periods. As of the date of issuance of these condensed consolidated financial statements, the Company is not aware of any specific event or circumstances that would require the Company to update estimates, judgments or revise the carrying value of any assets or liabilities. Actual results may differ from those estimates or assumptions.
Intangible assets, net
The Company’s finite-lived intangible assets consist of developed technology and trademarks acquired in business combinations, as well as computer software acquired or capitalized in the ordinary course of business, including off-the-shelf software applications and costs associated with systems implementations. Finite-lived intangible assets are recorded at cost or, for assets acquired in a business combination, at their estimated acquisition-date fair values, less accumulated amortization and impairment. These assets are amortized on a straight-line basis over their estimated useful lives, which approximates the pattern in which the related economic benefits are expected to be consumed. Acquired developed technology is amortized over 15 years, trademarks are amortized over two years, off-the-shelf software is amortized over three years, and systems implementation costs are amortized over the initial license term. Annual license fees for off-the-shelf software are expensed as incurred. Finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable.
Sales of future revenues
On November 20, 2020, the Company entered into an agreement with the Canada Strategic Innovation Fund (“SIF”), wherein SIF committed to providing a conditionally repayable loan to the Company in the amount of up to C$40.0 million (the “SIF Loan”). The SIF Loan is conditionally repayable according to a revenue-based formula. See Note 9 - Loans payable, net for additional information concerning the SIF Loan.
The accounting treatment for the SIF Loan considers the “sale of future revenues” guidance promulgated by ASC 470-10-25. The debt arising from the SIF Loan was recorded at face value and will be amortized using the effective interest method, leading to the accrual of interest expenses over the estimated term of the SIF Loan. The amortization schedule is based on projected cash flows derived from the Company's long-term revenue forecast. Subsequent changes in forecasted cash flows will be accounted for under the catch-up method, which entails adjusting the accrued interest portion of the principal balance through earnings to reflect the currently projected effective interest rate. The liability is classified as non-current, as the current forecast indicates that repayments will not commence within the 12 months following the balance sheet date.
As the SIF Loan is originated through a government program, a market rate of interest is not imputed in accordance with the scope limitation provisions of ASC 835.

11


Fair value of financial instruments
Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:
•Level 1—Quoted prices in active markets for identical assets or liabilities.
•Level 2—Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.
•Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.
The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company recognizes transfers between levels of the fair value hierarchy on the date of the event or change in circumstances that caused the transfer. No assets or liabilities were classified as Level 3 during the nine months ended September 30, 2026 or 2025.
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2026 and indicates the place in the fair value hierarchy of the valuation inputs the Company utilized to determine each such fair value (in thousands):
DescriptionLevelAs of September 30, 2026
Assets:
U.S. government bonds1$123,990 
Time deposits2$100,000 
Revenue recognition
The Company recognizes revenue in accordance with Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) and accounts for certain contract costs in accordance with FASB’s Accounting Standards Codification (“ASC”) 340-40, Other Assets and Deferred Costs-Contracts with Customers.
The core principle of ASC 606 is that an entity shall recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.
To support this core principle, the Company applies the following five step approach:
Step 1: Identify the contract with the customer
The Company executes signed contracts with customers for services sold through either its direct sales force or various reseller channels. Payment terms vary by arrangement and may include net 30 to 60-day terms, milestone billings, advance payments, and installment payments.
In arrangements with re-sellers of the Company’s services, the re-seller is considered the customer and the Company does not have any contractual relationships with the re-sellers’ end users. For these arrangements, revenue is recognized at the amount charged to the re-seller.
Upon initiation of a customer contract, an assessment is conducted by the Company regarding the customer's ability to pay for the services and/or products provided. This assessment encompasses various factors such as the customer's creditworthiness and past transaction history. Furthermore, periodic evaluations of customers' financial conditions are performed by the Company. The Company generally does not provide rights of return unless explicitly stated in the underlying contract.
Step 2: Identify the performance obligations
The Company’s contracts with customers often include multiple performance obligations. The Company's revenue contracts typically include one or more of the following performance obligations:

12


•Subscription access to its Leap service
•Professional services related to the development and implementation of quantum computing applications or to paid research projects
•Quantum computing systems, including related installation, calibration, commissioning, and customer-specific upgrade services when those promises are not separately identifiable
•Ongoing support and maintenance services
•Quantum computing application or system training
•Customer options, renewals, or future upgrade rights that may represent material rights.
The Company evaluates whether promised goods and services are distinct and therefore separate performance obligations, or whether they should be combined into a single performance obligation because they are not separately identifiable in the context of the contract.
Step 3: Determine the transaction price
The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring goods and services to the customer. Transaction prices may include fixed consideration, variable consideration, milestone payments, advance payments, installment payments, or other contractual amounts.
The Company evaluates whether variable consideration exists, including price concessions, credits, or service-level credits, and includes such amounts in the transaction price only to the extent that it is probable that a significant reversal of cumulative revenue recognized will not occur. The Company also evaluates whether payments to or on behalf of a customer should be accounted for as consideration payable to a customer rather than as a separate expense.
The Company assesses whether the contract contains a significant financing component by considering the difference between the promised consideration and the cash selling price of the promised goods or services, the timing of payments relative to transfer of control, the reason for that timing difference, and the discount rate that would apply in a separate financing transaction between the parties at contract inception. The Company has elected the practical expedient that permits an entity not to recognize a significant financing component if the time between the transfer of a good or service and payment is one year or less. When a significant financing component exists, the Company adjusts the transaction price to reflect the cash selling price of the promised goods or services and recognizes the financing effect separately from revenue using the effective-interest method.
The Company excludes from revenue government-assessed and imposed taxes on goods and services that are invoiced to customers.
Step 4: Allocate the transaction price to the performance obligations
When the Company determines that its contracts with customers contain multiple performance obligations, for these arrangements, the Company allocates the transaction price based on the relative standalone selling price (“SSP”) basis method by comparing the SSP of each distinct performance obligation to the total value of the contract. The Company uses SSP for products and services sold together in a contract to determine whether there is a variable consideration (e.g. discount) to be allocated based on the relative SSP of the various products and services. In instances where SSP is not directly observable, such as when the Company does not sell the product or service separately, the Company determines the SSP by considering its overall pricing objectives and market conditions, including cost plus a reasonable margin. Significant pricing practices taken into consideration include the Company’s discounting practices, the customer demographic, price lists, the Company's go-to-market strategy, historical and current sales, and contract prices. In instances where the Company does not sell or price a product or service separately, the Company maximizes the use of observable inputs by using information that may include market conditions.
When a contract includes a material right, the Company estimates the SSP of that option and allocates a portion of the transaction price to the material right. Revenue allocated to a material right is deferred and recognized when the related option is exercised or when the option expires unexercised.
Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation
The Company recognizes revenue when or as control of the promised good or service transfers to the customer. The Company’s Leap service and support and maintenance services are obligations that are satisfied over time by providing the customer with ongoing access to the Company’s resources. The Company uses the straight-line measure of progress to recognize revenue as these performance obligations are satisfied evenly over the respective service periods.

13


The Company’s professional services constitute an activity that creates benefits that the customer receives as the work is being performed. Therefore, professional services revenue is generally recognized over time using the labor hours incurred as input measure of progress. Certain paid research projects may be recognized at a point in time when research milestones are delivered to and accepted by the customer.
Revenue from quantum computing system sales is generally recognized over time during the installation period using an input method, with progress measured based on costs incurred to date relative to total estimated costs. From time to time, performance obligations arising from system sales may be recognized at a point in time if the circumstances of a sale preclude over time recognition. Revenue from system upgrade projects is also generally recognized over time using an input method, measuring progress based on costs incurred to date relative to total estimated costs. In applying a cost-to-cost measure of progress, the Company includes only those costs that depict performance in transferring control to the customer and excludes costs associated with abnormal inefficiencies or wasted materials.
The Company’s training performance obligations are satisfied at a point in time when control of the service transfers from the Company to the customer.
Revenue allocated to a material-right performance obligation is not recognized when the base contract is executed. Instead, the allocated amount is recognized when the customer exercises the option and the underlying promised goods or services are transferred, or when the option expires unexercised.
Contract assets and contract liabilities
The timing of revenue recognition, billings and cash collections may result in accounts receivable, contract assets, and contract liabilities on the Company’s consolidated balance sheets. A receivable is recorded in the period in which the Company provides services when it has an unconditional right to payment. Contract assets arise when the Company has transferred goods or services to the customer but the right to payment is conditional on something other than the passage of time. Contract assets may also arise when the cost to fulfill performance obligations recognized at a point in time are deferred until the performance obligation is complete. Contract liabilities (also referred to as deferred revenue) arise when the Company receives consideration before transferring the related goods or services. Deferred revenue is classified as current or non-current based on the expected timing of revenue recognition.
When a significant financing component exists, the Company separately recognizes the financing element as interest income or interest expense, as applicable, rather than as revenue.
Our contract acquisition costs represent incremental direct costs of obtaining a contract, primarily consisting of commissions and other incremental contract acquisition costs. When these costs are determined to be recoverable, we defer and amortize them over the contract term. Unamortized contract acquisition costs are included in other non-current assets, net on the condensed consolidated balance sheets, with related amortization expense recorded in sales and marketing expenses on the condensed consolidated statements of operations and comprehensive loss. The Company has elected to apply the practical expedient to expense contract acquisition costs as incurred when the expected amortization period is one year or less.
Cost of revenue
Cost of revenue for services consists of expenses related to delivering the Company’s services, consisting of direct labor costs, including stock-based compensation, direct services costs and depreciation and amortization related to the Company’s quantum computing systems and related software. These costs are expensed as incurred, as they relate to performance obligations that are being simultaneously satisfied as the work is performed.
Cost of revenue for quantum computing systems includes direct manufacturing costs, such as materials and labor for system production, as well as expenses related to installation, calibration, warranty, and support. Additionally, it includes shipping and handling costs associated with delivering the systems.
For system arrangements recognized over time using a cost-to-cost input method, cost of revenue also includes customer-specific fulfillment costs that directly relate to satisfying the performance obligation, including installation-enablement and site-preparation activities incurred after contract execution. Such costs are recognized in a manner consistent with the Company’s measure of progress.

14


Business Combination
The Company accounts for business combinations using the acquisition method of accounting, which requires the consideration transferred to be measured at fair value and allocated to the identifiable assets acquired and liabilities assumed based on their estimated acquisition-date fair values. On January 20, 2026, the Company completed the acquisition of Quantum Circuits, Inc. (“Quantum Circuits”), which was accounted for as a business combination under ASC 805. In connection with the acquisition, the Company recognized developed technology and trademarks as identifiable finite-lived intangible assets, both of which were valued using the relief-from-royalty method with the assistance of an independent valuation specialist. The excess of the purchase price over the estimated fair values of the identifiable net assets acquired was recorded as goodwill. If the accounting for a business combination is incomplete at the end of a reporting period, provisional amounts are recorded and may be adjusted during the measurement period, not to exceed one year from the acquisition date, for new information about facts and circumstances that existed as of the acquisition date. The results of operations of acquired businesses are included in the Company’s results beginning on the acquisition date. Acquisition-related costs incurred by the Company are expensed as incurred, while seller transaction expenses reimbursed by the Company are included in consideration transferred.
Net loss per share
Basic net loss per common share is computed by dividing the net loss available to common stockholders (the numerator) by the weighted-average number of shares of common stock, par value $0.0001 per share (“Common Shares”) outstanding (the denominator) during the period. Diluted net loss per common share is computed by dividing the net loss available to common stockholders adjusted by any preferred stock dividends declared during the period by the weighted average number of Common Shares and potential Common Shares outstanding when the impact is not antidilutive. Contingently issuable shares are included in basic Earnings Per Share (“EPS”) only when there is no circumstance under which those shares would not be issued. Shares issuable for little or no cash consideration are considered outstanding Common Shares and included in the computation of basic EPS.
U.S. Department of Commerce Award and Securities Issuance Agreement
On September 4, 2026, the Company entered into an Other Transaction Agreement (the “OTA”) with the U.S. Department of Commerce (the “Department”) under the CHIPS and Science Act, under which the Department agreed to provide an award of up to $100.0 million (the “Award” or the “CHIPS Act Award”) to support research and development of the Company's annealing and gate-model quantum computing systems. The Award is disbursed in tranches subject to the achievement of specified milestones. In connection with the OTA, on September 8, 2026, the Company entered into a Securities Issuance Agreement (the “SIA”) with the Department and issued to the Department 7,095,721 shares of its common stock (the “Shares”) at an issuance price of $14.093 per share, with no cash exchanged at closing. Please see Note 14 - Stockholders' equity for additional discussion of the CHIPS Act Award.
The Company accounted for the transaction as an equity issuance, with the uncollected contingent proceeds classified as contra-equity by analogy to the stock sale receivables guidance provided by ASC 505-10-45-2 and ASC 310-10-S99-2. The Company recorded the issuance at the $100.0 million of maximum consideration under the arrangement, offset by an equal contra-equity account that will be relieved as funds are collected. The equity and the contra-equity arising from the SIA are each recorded in additional paid-in capital on the condensed consolidated balance sheets. As of September 30, 2026, the Company had not received any draws. Issuance costs of $1.1 million were recorded as a reduction to additional paid-in capital.
The OTA contains certain clawback provisions included as remedies for the Company’s material non-compliance with the OTA. These provisions are evaluated as potential loss contingencies. As of September 30, 2026, no loss under these provisions was probable, and no liability has been recognized.
Recent accounting pronouncements issued and adopted
None.
Recent accounting pronouncements not yet adopted
Expense Disaggregation Disclosures
In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

15


Capitalized Internal-Use Software Costs
In September 2025, the FASB issued ASU 2025-06, Accounting for Internal-Use Software Costs (Subtopic 350-40): Clarifying the Application of Capitalization Guidance, which amends the guidance on capitalizing costs related to internal-use software. ASU 2025-06 requires public entities to apply the disclosure requirements in ASC 360-10, Property, Plant, and Equipment, to capitalized internal-use software costs, regardless of how those costs are presented in the financial statements. The update is effective for fiscal years beginning after December 15, 2027, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-06.
Government Grants
In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities, which establishes comprehensive guidance for recognizing, measuring, presenting, and disclosing government grants received by business entities. Under this update, entities must apply specific recognition and measurement principles for both monetary and tangible non-monetary government grants, with the accounting outcome dependent on whether the grant is related to an asset or to income. ASU 2025-10 does not apply to not-for-profit entities and employee benefit plans and excludes certain types of transactions such as exchange transactions and government guarantees. The amendments are effective for fiscal years beginning after December 15, 2028, with early adoption permitted, and the Company is currently evaluating the impact of adopting ASU 2025-10.
3. BUSINESS COMBINATION
On January 20, 2026, the Company completed the acquisition of all of the issued and outstanding equity interests of Quantum Circuits, a privately held developer of superconducting gate-model quantum computing technology, pursuant to the Agreement and Plan of Merger dated January 6, 2026. The acquisition is intended to enhance the Company’s gate-model quantum computing capabilities by adding Quantum Circuits' dual-rail qubit technology and related intellectual property, together with complementary error-detection capabilities, to the Company’s scalable control systems, cryogenic infrastructure and cloud platform. The acquisition has been accounted for as a business combination under ASC 805, Business Combinations, with the Company identified as the accounting acquirer.
The Company incurred total acquisition-related costs of $12.0 million, including $2.9 million incurred during the year ended December 31, 2025. These costs were accounted for separately from the business combination and expensed as incurred in general and administrative expenses on the condensed consolidated statements of operations and comprehensive loss. Seller transaction expenses reimbursed by the Company were included in consideration transferred, while severance-related payments were recognized separately in post-combination compensation expense. In addition, the portion of replacement awards attributable to post-combination service will be recognized as compensation expense over the remaining service period.
The acquisition date was January 20, 2026, which is the date on which the Company obtained control of Quantum Circuits. The fair value of consideration transferred was $538.5 million, consisting of cash and equity consideration measured as of the acquisition date. The fair value of the Company’s Common Shares issued as consideration was based on the January 20, 2026 share price of $27.04 per share.
Consideration transferred was allocated to the tangible and intangible assets acquired and liabilities assumed based on their fair values as of the acquisition date. Management estimated the fair value of tangible and intangible assets and liabilities in accordance with the applicable accounting guidance for business combinations and utilized the services of third-party valuation consultants. The initial allocation of the consideration transferred is based on a preliminary valuation and may be adjusted as additional information becomes available during the measurement period. Balances subject to adjustment primarily include the valuations of acquired assets (tangible and intangible), liabilities assumed, as well as tax-related matters. During the measurement period, the Company may record adjustments to the provisional amounts recognized. The allocation of the consideration transferred will be finalized within the measurement period (up to one year from the acquisition date).
The following table summarizes the consideration transferred (in thousands):
Amounts
Cash consideration$256,030 
Equity consideration282,039 
Pre-acquisition portion of replacement equity awards439 
Acquisition Consideration$538,508 

16


As of the acquisition date, the Company recognized the identifiable assets acquired and liabilities assumed based on their estimated fair values as follows (in thousands):
Amounts
Assets:
Cash and cash equivalents$3,209 
Prepaid expenses and other current assets849 
Property and equipment, net5,272 
Operating lease right-of-use assets92 
Intangible assets217,150 
Goodwill342,588 
Total assets$569,160 
Liabilities:
Accounts payable$(1,579)
Current portion of right-of-use liability(77)
Accrued and other current liabilities(631)
Deferred Tax Liability(28,365)
Total liabilities$(30,652)
Total purchase price$538,508 
The recognition of deferred tax liabilities in connection with the acquisition resulted in the release of certain preexisting valuation allowances on deferred tax assets, which was recorded as a deferred tax benefit on the condensed consolidated statements of operations and comprehensive loss.

Identifiable Intangible Assets
The Company identified two finite-lived intangible assets, developed technology and trademarks. The fair values assigned to the acquired developed technology and trademarks were estimated with the assistance of an independent third-party valuation specialist using the relief-from-royalty method, which estimates the value of an intangible asset based on the present value of the hypothetical royalty payments that the Company is relieved from paying by owning the asset rather than licensing it from a third party. Significant assumptions used in the valuations included projected revenues attributable to the acquired technology and trademarks, selected market-based royalty rates, estimated useful lives, expectations regarding technological obsolescence and the continued use of the Quantum Circuits brand, applicable tax rates and discount rates commensurate with the risks associated with the projected cash flows. Developed technology was assigned a useful life of 15 years and trademarks were assigned a useful life of 2 years. These intangible assets are being amortized on a straight-line basis over their respective useful lives.
The following table summarizes the acquired intangible assets (in thousands):
AmountsUseful life
Developed technology$216,700 15 years
Trademarks4502 years
Total intangible assets$217,150 

Goodwill
Goodwill represents the excess of the purchase price over the fair value of the identifiable net assets acquired and reflects expected synergies, going-concern value, workforce-related value, and other future economic benefits that do not qualify for separate recognition. This goodwill is not deductible for income tax purposes.








17


Pro forma information (unaudited)
The following unaudited pro forma financial information presents the combined results of operations of the Company and Quantum Circuits as if the acquisition had occurred on January 1, 2025. The unaudited pro forma information includes adjustments for items directly attributable to the acquisition, including incremental amortization expense related to acquired intangible assets of $0.7 million and $11.0 million for the nine months ended September 30, 2026 and 2025, respectively, and non-recurring acquisition-related costs of $9.1 million assumed to have been incurred during the nine months ended September 30, 2025. The unaudited pro forma results do not reflect any operating efficiency or potential cost savings which may result from the integration of Quantum Circuits. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operation of the combined company would have been if the acquisition had occurred as of January 1, 2025.

Three Months Ended September 30,Nine Months Ended September 30,
(In thousands, except share and per share data)2026202520262025
Revenue$4,513 $4,034 $10,447 $22,330 
Loss from operations(53,482)(36,266)(155,402)(101,926)
Net loss$(48,197)$(163,595)$(108,506)$(364,277)
Net loss per share, basic and diluted$(0.13)$(0.46)$(0.29)$(1.14)
Weighted-average number of shares outstanding used to compute net loss per share, basic and diluted374,112,327352,635,275371,597,008320,939,449
Quantum Circuits Revenue and Net Loss
The following table represents Quantum Circuits' revenue and losses included in the Company's condensed consolidated statements of operations and comprehensive loss subsequent to the Quantum Circuits acquisition date (in thousands):
Period from January 20, 2026 through September 30, 2026
Revenue$1,263 
Net loss$(25,448)
4. REVENUE FROM CONTRACTS WITH CUSTOMERS
Disaggregation of revenue
Nature of Products and Services
The following table depicts the disaggregation of revenue by type of products or services and timing of transfer of products or services (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Type of products or services
System sales$330 $1,843 $671 $15,515 
QCaaS2,165 1,384 5,784 4,158 
Professional services1,989 476 3,901 2,038 
Other revenue*29 36 91 124 
Total revenue$4,513 $3,739 $10,447 $21,835 
Timing of revenue recognition
Revenue recognized over time$3,465 $3,733 $9,079 $9,152 
Revenue recognized at a point in time1,048 6 1,368 12,683 
Total revenue$4,513 $3,739 $10,447 $21,835 
*Other revenue includes support and maintenance and printed circuit board sales.




18


Geographic Information
The following table presents a summary of revenue by geography for the three and nine months ended September 30, 2026 and 2025, based on customer location (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
United States$3,502 $715 $7,367 $1,922 
Japan208 266 727 904 
Germany254 1,972 556 15,962 
Canada111 192 382 764 
Other438 594 1,415 2,283 
Total revenue$4,513 $3,739 $10,447 $21,835 
“Other” includes the rest of Europe, the Middle East, the rest of Asia and Australia where the revenue from a single country is not greater than 10% of total consolidated revenue. In accordance with Company policy, the Company has not had any sales in China, Russia or Ukraine.
Significant customers
A significant customer is defined as one that comprises ten percent or more of total revenues in a particular period or ten percent of outstanding accounts receivable balance as of the period end.
The tables below present the significant customers on a percentage of total revenue basis for the three and nine months ended September 30, 2026 and 2025.
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Customer A28 %— %32 %— %
Customer B20 %— %— %— %
Customer C— %51 %— %72 %
As of each of September 30, 2026 and 2025, there were three and two significant customers, respectively, that comprised ten percent or more of outstanding accounts receivable balances.
Contract balances
The following table provides information about accounts receivable, contract assets and liabilities as of September 30, 2026 and December 31, 2025 (in thousands):
As of September 30, 2026As of December 31, 2025
Trade accounts receivable and contract assets, net:
Trade accounts receivable, net of allowance for credit losses and excluding unbilled receivables$1,796 $1,021 
Unbilled receivable contract asset1,747 566 
Contract acquisition costs3,599 940 
Capitalized fulfillment costs123 — 
Total contract assets$7,265 $2,527 
Contract liabilities:
Deferred revenue, current$6,404 $2,778 
Deferred revenue, non-current2,188 560 
Total contract liabilities$8,593 $3,338 

19


The allowance for credit losses related to trade accounts receivable was nominal as of September 30, 2026 and December 31, 2025. During the three and nine months ended September 30, 2026 and 2025, the Company recorded no write-offs of accounts receivable deemed uncollectible, respectively.
The revenue recognized in the condensed consolidated statements of operations and comprehensive loss that was included in the contract liability balance at the beginning of each period was $2.4 million and $18.2 million for the nine months ended September 30, 2026 and 2025, respectively.
Changes in deferred revenue from contracts with customers were as follows (in thousands):
Nine Months Ended September 30,
20262025
Balance at beginning of period$3,338 $19,356 
Deferral of revenue15,686 6,510 
Recognition of deferred revenue(10,432)(21,848)
Balance at end of period$8,592 $4,018 
Remaining performance obligations
A significant number of the Company’s product and service sales are short-term in nature with a contract term of one year or less. For those contracts, the Company has utilized the practical expedient in ASC 606-10-50-14, exempting the Company from disclosure of the transaction price allocated to remaining performance obligations if the performance obligation is part of a contract that has an original expected duration of one year or less.
As of September 30, 2026, the aggregate amount of remaining performance obligations that were unsatisfied or partially unsatisfied related to customer contracts was $38.3 million, of which approximately 59% is expected to be recognized to revenue in the next 12 months and 71% is expected to be recognized to revenue in the next two years with the remainder to be recognized thereafter. Revenues allocated to remaining performance obligations represents the transaction price of noncancellable orders for which service has not been performed, which include deferred revenue and the amounts that will be invoiced and recognized as revenues in future periods from open contracts and excludes unexercised renewals.
5. MARKETABLE INVESTMENT SECURITIES
The Company holds investments in time deposits and in U.S. government bonds, which are classified as available-for-sale. The following table presents the components of the Company's available-for-sale debt securities as of September 30, 2026 and December 31, 2025:
Amortized CostUnrealized Estimated Fair Value
GainsLosses
As of September 30, 2026
U.S. government bonds
$124,047 $— $57 $123,990 
Time deposits$100,000 $— $— $100,000 
As of December 31, 2025
U.S. government bonds
$248,980 $154 $— $249,134 
As of September 30, 2026, the Company held $224.0 million of available-for-sale debt securities, all of which had contractual maturities of one year or less.


20


6. BALANCE SHEET DETAILS
Inventories
Inventories consisted of the following (in thousands):
As of September 30, 2026As of December 31,
2025
Raw materials$6,313 $2,746 
Work-in-process62 30 
Total inventories$6,375 $2,776 
Prepaid expenses and other current assets
Prepaid expenses and other current assets consisted of the following (in thousands):
As of September 30, 2026As of December 31,
2025
Prepaid services$2,419 $1,339 
Interest receivable1,897 3,093 
Prepaid software3,097 1,550 
Prepaid insurance205 421 
Prepaid rent238 182 
Other3,340 803 
Total prepaid expenses and other current assets$11,196 $7,388 

Other non-current assets, net
Other non-current assets, net consisted of the following (in thousands):
As of September 30, 2026As of December 31,
2025
Investment in equity securities$5,114 $2,391 
Deferred financing costs356 725 
Long-term deposits381 251 
Contract acquisition costs, net1,297 940 
Total $7,148 $4,307 
Equity Securities
During the nine months ended September 30, 2026, an observable transaction occurred in a class of securities held by the Company in one of our privately-held equity investees. Consequently, the carrying value of the Company’s investment was adjusted based on the transaction price, resulting in a net gain of $1.8 million. During the three months ended September 30, 2026 the Company received additional shares in an equity investee pursuant to an earn-out provision and recognized an additional net gain of $0.9 million. The gains are recorded in gain on investment in marketable securities, net on the condensed consolidated statements of operations and comprehensive loss.
Deferred financing costs
The deferred financing costs are deferred issuance costs related to the Equipment Financing Agreement. See Note 9 - Loans payable, net for additional information.

21


Accrued expenses and other current liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
As of September 30, 2026As of December 31,
2025
Accrued compensation and related benefits$11,347 $10,348 
Accrued professional services2,428 4,086 
Other accruals4,486 1,404 
Total accrued expenses and other current liabilities$18,261 $15,838 
7. PROPERTY AND EQUIPMENT, NET
Property and equipment, net consisted of the following (in thousands):
As of September 30, 2026As of December 31,
2025
Quantum computer systems$17,153 $15,028 
Lab equipment11,848 7,555 
Computer equipment6,945 5,659 
Leasehold improvements3,296 2,407 
Furniture and fixtures959 541 
Construction-in-progress9,733 2,514 
Total property and equipment49,934 33,704 
Less: Accumulated depreciation(22,857)(25,863)
Total property and equipment, net$27,077 $7,841 
Depreciation expense for the three months ended September 30, 2026 and 2025 was $1.2 million and $0.3 million, respectively. Depreciation expense for the nine months ended September 30, 2026 and 2025 was $3.0 million and $1.0 million, respectively.
8. INTANGIBLE ASSETS, NET
Intangible assets, net consisted of the following (in thousands):
As of September 30, 2026As of December 31,
2025
Developed technology$216,700 $— 
Trademarks450 — 
Acquired software648 1,335 
Internally developed software1,592 907 
Other intangible assets46 46 
Total intangible assets219,436 2,288 
Less: Accumulated amortization(11,014)(1,373)
Total intangible assets, net$208,422 $915 
Intangible assets are amortized on a straight-line basis over estimated useful lives ranging from 2.0 to 15.0 years, depending on the asset class, as described in Note 2 - Basis of Presentation and Summary of Significant Accounting Policies. Amortization expense for the three months ended September 30, 2026 and 2025 was $3.7 million and $49 thousand, respectively. Amortization expense for the nine months ended September 30, 2026 and 2025 was $10.5 million and $0.1 million, respectively.


22


Future Amortization
As of September 30, 2026, estimated future amortization expense is as follows (in thousands):
Amounts
2026 (remaining)$3,835 
202715,124 
202814,813 
202914,615 
203014,792 
Thereafter145,197 
9. LOANS PAYABLE, NET
Loans payable, net consisted of the following (in thousands):
Effective Interest RateAs of September 30, 2026As of December 31,
2025
Loans payable, net, current:
Equipment Financing Term Loan, current18.26%$1,946 $134 
Total loans payable, net, current$1,946 $134 
Loans payable, net, non-current:
SIF Loan
Variable1
$35,019 $35,525 
Equipment Financing Term Loan, non-current5,054 300 
Total loans payable, net, non-current$40,073 $35,825 
1Refer below for additional information on the SIF Loan repayment period and effective interest rate.
SIF Loan
On November 20, 2020, the Company entered into the SIF Loan and subsequently received the full C$40.0 million in eight tranches between November 2020 and December 2023. Funds from the SIF Loan were used for various research and development projects.
Principal and interest amounts to be repaid under the SIF Loan are determined using a revenue-based formula, and are capped at 150% of the principal amount. Repayments are due in up to 15 annual installments, commencing on April 30 of the second fiscal year following the fiscal year in which the Company first reports annual revenue of at least $70.0 million. If the Company fails to reach $70.0 million in annual revenue after 14 years from origination, or if the total of the 15 revenue-based annual installments is less than the principal amount, any remaining repayment obligation will be forgiven.
Repayments of the SIF Loan can also be triggered upon default of the agreement, termination of the agreement, or upon a change of control that has not been approved by the Canadian government. As of September 30, 2026, the Company is not aware of any events that would trigger default or termination of the agreement.
The gross proceeds of the SIF Loan were recorded as a liability related to the sale of future revenues (see Note 2 - Basis of Presentation and Summary of Significant Accounting Policies). As of September 30, 2026 and December 31, 2025, the Company calculated a weighted average effective interest rate for all tranches of 2.61% based on the most recent long-term revenue projections at each reporting date.
The estimated fair value of the SIF Loan (Level 3) at September 30, 2026 was $15.0 million. The fair value of SIF Loan was valued using a discounted cash flow model, with significant assumptions relating to the amount and timing of future revenues and the appropriate discount rate.

23


Equipment Financing Term Loan
On August 1, 2025, the Company entered into an equipment financing agreement (the “Equipment Financing Agreement”). The agreement provides for a total conditional commitment of $13.8 million, with an initial draw of $0.5 million made upon execution. Amounts drawn under the agreement are recognized as a term loan (the “Equipment Financing Term Loan”). The remaining commitment is available until February 1, 2027, which may be extended to August 1, 2027 if at least $11.5 million is drawn by that date. On September 2, 2026, the Company drew an additional $7.2 million under the Equipment Financing Agreement.
A commitment fee of 1% of the total conditional commitment was paid to the financial institution providing the Equipment Financing Agreement (the “Lender”) upon the initial draw. The Lender also received a ten-year warrant to purchase 21,563 Common Shares at an exercise price of $16.05 per share. A non-utilization fee of 3% will apply to the undrawn portion of the first $11.5 million as of the termination date (either February 1, 2027 or August 1, 2027, as applicable).
The interest rate for each draw is fixed upon execution and is based on a spread of approximately 3.4% over the Prime Rate (which was 7.5% at signing), subject to a minimum rate of 10.9%, which is the rate applied to the initial draw. The Lender holds a first-priority security interest in all financed equipment. The rate applied to the September 2026 draw is the same as the rate for the initial draw.
Debt issuance costs, including the commitment fee, legal and documentation costs, and the warrant value, are recorded as deferred issuance costs and reclassified to a contra-liability as draws are made. The End-of-Term Payment (4.0% of the total amount financed under the Equipment Financing Agreement) is accreted as part of the loan’s effective interest rate. Deferred issuance costs are reviewed for recoverability, and any unamortized costs related to canceled draws or terminated facilities are expensed immediately. Cash payments for debt issuance costs are classified as financing activities in the condensed consolidated statements of cash flows.
As of September 30, 2026, the Company had drawn $7.7 million under the Equipment Financing Agreement. The carrying amount of the outstanding equipment financing at September 30, 2026 was $7.0 million, measured at amortized cost net of discounts. As of September 30, 2026, $0.6 million in deferred issuance costs had been reclassified to debt discount related to the draws and $0.4 million of deferred issuance costs remained unallocated.
The estimated fair value of the Equipment Financing Term Loan was $7.3 million (Level 2) at September 30, 2026. The fair value of the Equipment Financing Term Loan was valued using a discounted cash flow model, with key inputs relating to terms, discount rate and expectations for defaults and prepayments.
TPC Loan
During the period spanning 2010 through 2021, the Company received funding totaling C$12.5 million from Technology Partnerships Canada (the “TPC Loan”). On November 23, 2020, an amendment forgave C$5.0 million of unpaid accrued debt principal and interest from prior years. Additionally, the amendment waived the interest charge on the remaining C$2.5 million of principal and revised the repayment schedule to C$0.5 million due annually on each April 30 through 2025. The TPC Loan was fully repaid on April 24, 2025.

24


10. WARRANT LIABILITIES
Public and Private Warrants
In conjunction with the Merger, the Company assumed 10,000,000 Public Warrants and 8,000,000 Private Warrants. As part of the Merger, each Public Warrant and Private Warrant that was issued and outstanding immediately prior to the Merger was automatically and irrevocably converted into one warrant of the Company.
Each such Warrant was exercisable at an exercise price of $11.50 for 1.4541326 Common Shares, or an approximate exercise price per Common Share of $7.91, subject to adjustments. The Warrants were exercisable only for a whole number of Common Shares, and no fractional shares were issuable. The Warrants were originally scheduled to expire on August 5, 2027, unless earlier redeemed or liquidated.
Warrant Exercises
During the year ended December 31, 2025, 17,645,147 Warrants were exercised by holders in accordance with the Warrant Agreement. As a result of these exercises, during the year ended December 31, 2025, the Company issued 25,658,383 Common Shares. In connection with the exercises, during the year ended December 31, 2025, the Company received cash proceeds of $202.9 million and reclassified $340.4 million, representing the fair value of the warrant liabilities at the time of exercise, from warrant liabilities to additional paid-in capital. The fair value of the liability pertaining to the exercised Warrants was remeasured immediately prior to exercise, and the change in fair value was recognized within change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss.
Redemption of Warrants
On November 19, 2025, the Company redeemed the 270,820 remaining outstanding Public Warrants at a redemption price of $0.01 per warrant. The redemption was effected pursuant to the terms of the Warrant Agreement following the Company’s satisfaction of the applicable share price performance condition. As a result of the redemption, the Public Warrants ceased trading on the New York Stock Exchange prior to the redemption date and were subsequently delisted.
There were no Public or Private Warrants outstanding at September 30, 2026.
D-Wave Systems Warrant Transaction Agreements
In November 2020, contemporaneously with a revenue arrangement, D-Wave Systems entered into a contract pursuant to which D-Wave Systems agreed to cancel a previously issued warrant with a customer and replace it with a warrant to acquire up to 3,247,637 shares of its Class A Preferred Shares (the “Warrant Preferred Shares”), subject to certain vesting requirements. The warrant agreement was amended on August 5, 2022, contemporaneously with the closing of the Merger, to convert the Warrant Preferred Shares to a warrant to acquire up to 2,889,282 Common Shares of the Company in accordance with the conversion ratio of 0.889657 established in the Merger. The warrants vest based on various contractual milestones. The warrant agreement was terminated on November 28, 2022. As of the termination date of the agreement, approximately 40% of the warrants had vested, resulting in warrants exercisable for up to 1,155,713 Common Shares remaining after the termination date. The vested warrants will remain exercisable for up to 1,155,713 Common Shares at an exercise price of $2.16 per Common Share until November 29, 2026. As of September 30, 2026, no additional Warrant Preferred Shares were vested or were probable of vesting.
Warrants Issued in Connection with Equipment Financing
In connection with the Equipment Financing Agreement, the Company issued warrants to purchase 21,563 Common Shares, as further described in Note 9 - Loans payable, net.
11. STOCK-BASED COMPENSATION
2020 Equity Incentive Plan
In April 2020, the Board of Directors of D-Wave Systems approved the 2020 Equity Incentive Plan (the “2020 Plan”) which provides for the grant of qualified incentive stock options (“ISO”) and non-qualified stock options (“NSO”), restricted stock, restricted stock units (“RSUs”) or other awards to the Company’s employees, officers, directors, advisors, and outside consultants. Following the Merger, awards outstanding under the 2020 Plan continued to be governed by the 2020 Plan; however, the Company will not grant any further awards under the 2020 Plan.

25


2022 Equity Incentive Plan
On August 5, 2022, the shareholders approved the D-Wave Quantum Inc. 2022 Equity Incentive Plan (the “2022 Plan”), which became effective immediately upon the closing of the Merger. While the 2022 Plan allows for the issuance of awards with a service condition, a performance condition, a market condition, or some combination of the three, to date, the Company has only issued awards subject to a service condition. Awards issued under the 2022 Plan have vesting periods ranging from under 1 year to 4 years from the original grant date, and all awards issued to date under the 2022 Plan will expire 10 years from the original grant date.
Share-based compensation awards are settled by issuing new shares.
Common stock option activity
The following table summarizes the Company’s stock option activity during the periods presented (in thousands except share and per share data):
Number of optionsWeighted  average  exercise price  ($)Weighted
average
remaining
contractual
term
(years)
Aggregate
intrinsic
value
($)
Outstanding as of December 31, 20253,608,1701.90 6.3687,511 
Granted592,3922.64 
Exercised(1,388,005)1.27 
Forfeited and expired(30,277)2.38 
Outstanding as of September 30, 20262,782,2802.36 6.2439,532 
Options exercisable as of September 30, 20261,992,6722.39 5.6828,248 
Options unvested as of September 30, 2026789,6082.28 7.6611,284 
Restricted stock unit awards
The following table summarizes the RSU activity and related information under the 2022 Plan:
Number of RSUsWeighted average Grant Date Fair Value ($)
Unvested as of December 31, 20258,215,915 6.56 
Granted3,447,539 21.43 
Forfeited and expired(639,927)8.84 
Vested(2,847,645)6.40 
Unvested as of September 30, 20268,175,882 12.71 
Stock-based compensation expense
The following table summarizes the stock-based compensation expense classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Cost of revenue$449 $221 $913 $594 
Research and development5,069 2,36114,7346,144
General and administrative3,380 2,766 9,4707,666
Sales and marketing1,769 1,107 4,6822,715
Total stock-based compensation$10,667 $6,455 $29,799 $17,119 
During the three months ended September 30, 2026 and 2025, total compensation cost capitalized as part of property and equipment and intangible assets was $0.1 million and $0.1 million, respectively. During the nine months ended September 30, 2026 and 2025, total compensation cost capitalized as part of property and equipment, intangible assets and contract assets was $0.6 million and $0.3 million, respectively.

26


As of September 30, 2026, total unrecognized stock-based compensation cost, net of estimated forfeitures, related to our unvested stock awards was $105.4 million. This amount is based on an estimated future forfeiture rate of 2.34% per year and will be recognized over a weighted-average period of approximately 2.9 years.
12. COMMITMENTS AND CONTINGENCIES
Lease obligations
The Company primarily enters into leases for office space that are classified as operating leases. During the three months ended September 30, 2026 and 2025, total operating lease costs were $1.2 million and $0.4 million, respectively. During the nine months ended September 30, 2026 and 2025, total operating lease costs were $3.3 million and $1.5 million, respectively.
Litigation
From time to time, the Company may become involved in various legal proceedings in the ordinary course of its business and may be subject to third-party infringement claims.
In the normal course of business, the Company may agree to indemnify third parties with whom it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company, with respect to certain matters. The Company has agreed, under certain conditions, to hold these third parties harmless against specified losses, such as those arising from a breach of representations or covenants, other third-party claims that the Company’s products, when used for their intended purposes, infringe the intellectual property rights of such other third parties, or other claims made against certain parties. It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the Company’s limited history of prior indemnification claims and the unique facts and circumstances that are likely to be involved in each particular claim.
As of September 30, 2026, the Company was not subject to any material litigation or pending litigation claims. Subsequently, the Company received notice of the following matters:
Securities Litigation
On October 15, 2026, a putative stockholder class action was filed in the United States District Court for the Northern District of California against the Company and certain current and former members of our senior management, captioned Fessler v. D-Wave Quantum Inc., et al. (Case No. 3:26-cv-11953). On October 20, 2026, another action was filed in the same court captioned Lawrence v. D-Wave Quantum Inc., et al. (Case No. 3:26-cv-12155). Each action (together, the “Actions”) asserts claims under Sections 10(b) and 20(a) of the Exchange Act, alleging that the Company and certain of its current and former officers made materially false or misleading statements, including about the Company’s operational and financial performance and growth. The plaintiffs in the Actions seek unspecified monetary damages and an award of costs and expenses, including reasonable attorneys’ fees and expert fees. We believe these claims are without merit, and we intend to defend the matters vigorously.
On November 2, 2026, a stockholder, Christopher Crull, filed a derivative lawsuit in the United States District Court for the Northern District of California, Crull v. Baratz, et al. (Case No. 5:26-cv-13006), against the Company (as nominal defendant only) and certain of the Company’s current and former directors and officers for, among other things, breach of fiduciary duty. The complaint alleges that the named directors and officers issued or caused the Company to issue materially false or misleading statements, including about the Company’s performance and growth and the Company’s internal controls, and that the Company suffered damages as a result. The complaint seeks, among other things, unspecified damages and reforms to the Company’s corporate governance and internal procedures.
The ultimate outcome of any litigation is uncertain and unfavorable outcomes could have a negative impact on our results of operations and financial condition. Defending such proceedings is costly and can impose a significant burden on management and team members. The results of litigation cannot be predicted with certainty, but regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
As we are unable to determine at this time whether any loss ultimately will occur or to estimate the range of such loss, no amount of loss has been accrued by us in our financial statements as of and for the three and nine months ended September 30, 2026. If the potential loss from any claim or legal proceeding is considered probable and the amount is reasonably estimable, we will accrue a liability for the estimated loss. Legal proceedings are inherently uncertain and as circumstances change, it is possible that the amount of any accrued liability may increase, decrease or be eliminated.

27


There are currently no other pending or, to our knowledge, threatened legal proceedings or claims against us that, in our opinion, are likely to have a material adverse effect on our business, operating results, financial condition or cash flows.
13. NET LOSS PER SHARE
The following tables set forth the computation of the basic and diluted net loss per share attributable to common stockholders for the three and nine months ended September 30, 2026 and 2025 (in thousands, except share and per share data):

Three Months Ended September 30,
20262025
Numerator:
Net loss attributable to common stockholders - basic and diluted$(48,197)$(139,986)
Denominator:
Weighted-average common stock outstanding374,112,327 342,204,831 
Net loss per share attributable to common stockholders - basic and diluted$(0.13)$(0.41)


Nine Months Ended September 30,
20262025
Numerator:
Net loss attributable to common stockholders - basic and diluted$(114,582)$(312,736)
Denominator:
Weighted-average common stock outstanding370,832,873 310,509,005 
Net loss per share attributable to common stockholders - basic and diluted$(0.31)$(1.01)
Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential Common Shares outstanding would have been anti-dilutive.
Potentially dilutive securities (upon conversion) that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:
As of September 30,
20262025
Public Warrants as converted to Common Shares (Note 10)— 8,401,203 
D-Wave Systems Warrant Preferred Shares as converted to Common Shares (Note 10)1,155,713 1,155,713 
Equipment Financing Agreement Warrant – Common Shares (Note 9)21,563 21,563 
Stock options issued and outstanding2,782,280 6,070,732 
Unvested restricted stock unit awards8,175,882 10,252,035 
Total12,135,438 25,901,246 

28


14. STOCKHOLDERS' EQUITY
Preferred Stock
As of September 30, 2026, D-Wave Quantum Inc. is authorized to issue up to 20,000,000 shares of preferred stock. D-Wave Quantum Inc. has not issued any shares of preferred stock as of September 30, 2026 and 2025. As no shares have been issued, D-Wave Quantum Inc. preferred stock is not reflected on the consolidated balance sheet.
Equity Purchase Agreements
On January 10, 2025, the Company entered into its third at-the-market sales agreement (the “$150M ATM”), with Needham & Company, LLC, Stifel, Nicolaus & Company, Incorporated, B. Riley Securities, Inc., Roth Capital Partners, LLC, The Benchmark Company, LLC, and Craig-Hallum Capital Group, LLC (the “$150M ATM Agents”). Under this agreement, the Company could sell Common Shares with an aggregate offering price of up to $150.0 million through or to the $150M ATM Agents. During the three months ended March 31, 2025, the Company received $146.1 million in net proceeds through the issuance of 24,604,021 Common Shares. As of September 30, 2026, the Company had completed 100% of the issuances available under the $150M ATM.
On June 10, 2025, the Company entered into its fourth at-the-market sales agreement (the “$400M ATM”), with Needham & Company, LLC, Evercore Group L.L.C., TD Securities (USA) LLC, Canaccord Genuity LLC, Mizuho Securities USA LLC, Piper Sandler & Co., Craig-Hallum Capital Group LLC and Rosenblatt Securities Inc. (collectively, the “$400M ATM Agents”). Under this agreement, the Company could sell Common Shares with an aggregate offering price of up to $400.0 million through or to the $400M ATM Agents. During the three months ended June 30, 2025, the Company received $390.6 million in net proceeds through the issuance of 26,344,831 Common Shares. As of September 30, 2026, the Company had completed 100% of the issuances available under the $400M ATM.
Sales under these agreements were classified as “at-the-market” equity offerings under Rule 415(a)(4) of the Securities Act and conducted on the NYSE or other trading platforms. The $150M ATM Agents and $400M ATM Agents (collectively, the “Agents”) used commercially reasonable efforts to sell shares based on the Company’s instructions. The compensation to the Agents was up to 3.0% of the gross sales price, along with expense reimbursements. The Company also agreed to provide indemnification against certain liabilities under the Securities Act.
The Company was not obligated to sell shares under either of these sales agreements. Each agreement could have been terminated by: (a) the election of the applicable Agents upon the occurrence of certain adverse events, (b) five business days’ advance notice from the Company to the applicable Agents or five days’ advance notice from any of the applicable Agents to the Company or (c) otherwise by mutual agreement of the parties pursuant to the terms of the applicable sales agreement.
U.S. Department of Commerce Award and Securities Issuance Agreement
On September 4, 2026 (the “Award Date”), the Company entered into the Other Transaction Agreement with the U.S. Department of Commerce under the CHIPS and Science Act. The Department agreed to provide an award of up to $100.0 million to support research and development of the Company's annealing and gate-model quantum computing systems. The OTA contains other terms and conditions that are customary for agreements with the Department, including provisions giving the U.S. government a license to use intellectual property funded by the Award for government purposes, as well as march-in rights and provisions requiring domestic control and production of federally-funded inventions. The Department also has the right to exercise specified remedies, including termination and clawback provisions, upon the Company’s non-compliance with the OTA.
On September 8, 2026, in connection with the OTA, the Company entered into the Securities Issuance Agreement with the Department. Under the SIA, the Company issued 7,095,721 shares of common stock, par value $0.0001 per share, to the Department at $14.093 per share, or approximately $100.0 million in the aggregate. The issuance price equals the lowest reported closing price of the Company’s common stock on three dates (the date the Department first transmitted the draft letter of intent for the Award to the Company, the date the letter of intent was executed, and the Award Date), discounted by 15%; the applicable reference price of $16.58 per share equaled the closing market price of the common stock on the Award Date.
The Award is disbursed in tranches based on the achievement of specified milestones. Of the total, $53.6 million became available at the Award Date; the remaining $46.4 million is subject to milestone achievement determinations made by the Department in its sole discretion. Funds drawn from the Award Date tranche or a subsequent tranche must be applied to eligible project costs within 30 days or returned. As of September 30, 2026, the Company has not received any funds pursuant to the Award.

29


While the Shares are held by a U.S. governmental entity or instrumentality or an entity in which the U.S. government holds a majority, controlling interest, the holder may not vote the Shares, except on matters as to which the holder is entitled to vote as a matter of law that would adversely affect the rights of the stock, or any business combination involving the Company. Absent the Company’s prior written consent, the Department may transfer only up to the number of Shares corresponding to the portion of the Award the Company has drawn (net of amounts returned); may not transfer any Shares from the time it delivers a notice terminating the OTA for convenience until 150 days after the end of the Award Period (or, if the Company exercises its repurchase right, until the related repurchase closing period expires); and may not transfer Shares in a privately negotiated transaction to a competitor or prospective competitor of the Company or to a transferee whose ownership of the Shares could cause the Company to violate the OTA.
The Department may terminate the OTA for convenience on 60 days’ prior written notice. If it does so before the end of the Award Period, the Company has the right, but not the obligation, exercisable by notice delivered no earlier than 120 and no later than 150 days after the end of the Award Period, to repurchase for $1.00 in aggregate, a number of Shares equal to the total Shares issued to the Department multiplied by the sum of the Award funds the Company did not receive plus any Award funds the Company returned to the Department prior to being applied to eligible project costs, divided by $100.0 million.
Warrant Exercises and Redemption
During the year ended December 31, 2025, 17,645,147 Warrants were exercised by holders in accordance with the terms of the Warrant Agreement. Refer to Note 10 - Warrant liabilities for further description of the Warrant exercises and redemption.
Common Shares
As of September 30, 2026, the Company had 379,681,691 shares of common stock outstanding, comprised of 3,176,096 Exchangeable Shares and 376,505,595 Common Shares. At any time and at their election, holders of Exchangeable Shares can exchange their shares for Common Shares on a one-for-one basis. In addition, holders of Exchangeable Shares have the same rights with respect to voting, dividends, and liquidation, dissolution, and winding up, as holders of Common Shares. As such, the Exchangeable Shares are identical in substance to Common Shares and, therefore, are treated as shares of common stock of the Company.
The rights pertaining to the Common Shares are as follows:
Voting Rights
Except as otherwise required by law or as otherwise provided in any certificate of designation for any series of preferred stock, the holders of Common Shares possess all voting power for the election of directors and all other matters requiring stockholder action. Holders of Common Shares are entitled to one vote per share on matters to be voted on by stockholders.
Dividend Rights
Holders of Common Shares will be entitled to receive dividends as and when declared by the Company's board of directors at its discretion out of funds properly applicable to the payment of dividends, subject to the rights, if any, of shareholders holding shares with special rights to dividends. The timing, declaration, amount and payment of future dividends will depend on the Company's financial condition, earnings, capital requirements and debt service obligations, as well as legal requirements, regulatory constraints, industry practice and other factors that the Company's board of directors deems relevant.
Rights Related to Liquidation, Dissolution and Winding Up
In the event of voluntary or involuntary liquidation, dissolution, distribution of assets or winding-up, the holders of Common Shares will be entitled to receive an equal amount per share of all of the Company's assets of whatever kind available for distribution to stockholders, after the rights of the holders of the preferred stock, if any, have been satisfied.

30


15. SEGMENT AND GEOGRAPHIC INFORMATION
The Company operates as one operating segment managed on a consolidated basis. The financial information regularly reviewed by the Chief Executive Officer, who serves as the Chief Operating Decision Maker (“CODM”), is presented on the same basis as the Company's consolidated financial statements. The measure of profit or loss used by the CODM to allocate resources and assess performance is consolidated net loss. Significant expense categories are not presented, as the expense information regularly provided to the CODM is presented on the same basis as the consolidated statements of operations and comprehensive loss. The CODM relies on consolidated net loss as a comprehensive measure of the Company, considering all revenues and expenses, including cost of revenue, research and development expenses, general and administrative expenses and sales and marketing expenses, to assess the Company’s overall performance and inform strategic decisions on cost control, pricing and investments. Additionally, the CODM reviews total assets to assess the Company's financial position and resource allocation. The CODM also reviews forward-looking expense information contained in budgets and operating plans to manage operations and allocate resources.
See the condensed consolidated financial statements and accompanying footnotes for consolidated net loss, total expenditures for additions to long-lived assets, total assets and other financial information regarding the Company’s single operating segment. See Note 4 - Revenue from contracts with customers for additional information about revenue by geography.
The following table sets forth the long-lived assets, consisting of property and equipment, net and operating lease right-of-use assets, by geographic area as follows (in thousands):
As of September 30, 2026As of December 31, 2025
Canada$21,521 $13,802 
United States19,062 515 
Other33 42 
Total long-lived assets$40,616 $14,359 

31


Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our unaudited condensed consolidated financial statements and the accompanying notes contained in Part I, Item 1 of this Report, as well as our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on February 26, 2026. The following discussion contains forward-looking statements based upon current expectations that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including risks described in this Report, and the risk factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2025 and our other filings with the SEC. Our historical results are not necessarily indicative of the results that may be expected for any period in the future. In this section, unless otherwise specified, the terms “we”, “our”, “us”, “D-Wave” or the “Company” refer to D-Wave Quantum Inc. and its subsidiaries following the closing of the Merger while “D-Wave Systems” refers to D-Wave Systems Inc. prior to such closing. All other capitalized terms have the meanings ascribed thereto elsewhere in this Report. All dollar amounts are expressed in thousands of United States dollars (“$”), unless otherwise indicated.

32


Overview
We are focused on the development and delivery of quantum computing systems, software, and services. We are the world’s first commercial supplier of quantum computers, and the first to offer dual-platform quantum computing products and services, spanning both annealing and gate-model quantum computing technologies. Our superconducting quantum computers provide sub-second response times and can be deployed on-premises or accessed through our LeapTM quantum cloud service (the “Leap service”), which offers 99.9% availability and uptime. Customers apply our technology to address use cases spanning optimization, artificial intelligence, research and more. Our current sixth-generation annealing quantum computing system is named Advantage2.
Our business model is focused on generating revenue from providing customers access to our quantum computing systems via the cloud in the form of quantum computing as a service (“QCaaS”) products, providing professional services wherein we assist our customers in identifying and implementing quantum computing applications, and selling our quantum computer systems to customers.
We have four operating facilities, which we lease, in North America. These facilities are located in Burnaby, British Columbia, Richmond, British Columbia, Palo Alto, California, and New Haven, Connecticut. In addition, we plan to transition our corporate headquarters from Palo Alto, California to Boca Raton, Florida, and open a key U.S. R&D facility there under a new lease agreement.
During the nine months ended September 30, 2026 and 2025, we generated revenue totaling $10.4 million and $21.8 million, respectively. We have incurred significant operating losses since inception. For the nine months ended September 30, 2026 and 2025, our operating losses were $161.5 million and $65.5 million, respectively, and our net losses were $114.6 million and $312.7 million, respectively. We expect to continue to incur significant losses for the foreseeable future as we continue to invest in a number of research and development programs as well as a variety of go-to-market initiatives. As of September 30, 2026, we had an accumulated deficit of $1.1 billion.
Acquisition of Quantum Circuits, Inc.
On January 20, 2026, we completed the acquisition (the “Acquisition”) of all of the issued and outstanding equity of Quantum Circuits, Inc. (“Quantum Circuits”), pursuant to the Agreement and Plan of Merger, dated January 6, 2026, by and among the Company, Quantum Circuits, Quest Acquisition Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company, Quest Acquisition Merger Sub II, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company, and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as the representative, agent and attorney-in-fact of the Securityholders (as defined therein) (the “Acquisition Agreement”). The aggregate consideration (the “Acquisition Consideration”) delivered at the closing of the Acquisition consisted of 10,430,444 Common Shares (the “Stock Consideration”) and $250,000,000 in cash, subject to a net debt adjustment and such other adjustments as set forth in the Acquisition Agreement. The issuance and sale of the Stock Consideration was made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act, Regulation D and/or Regulation S promulgated under the Securities Act. In accordance with the Acquisition Agreement, we assumed outstanding unvested options to purchase shares of Quantum Circuits common stock and adjusted such assumed options into options to purchase our Common Shares. Vested options and warrants to purchase Quantum Circuits common stock were cancelled in exchange for a pro rata portion of the Acquisition Consideration, subject to the adjustments described in the Acquisition Agreement.
Concurrently with the execution and delivery of the Acquisition Agreement, we entered into a lock-up agreement (each, a “Lock-Up Agreement”) with specified key employees of Quantum Circuits (each, a “Key Employee”) with respect to a portion of the Common Shares received as Acquisition Consideration, pursuant to which, subject to certain exceptions, each Key Employee may not transfer 50% of the Common Shares received by such Key Employee as Acquisition Consideration for a period of five years, subject to the terms and conditions of the Lock-Up Agreement, including accelerated release in specified events.
In addition, we and the former securityholders of Quantum Circuits (the “Securityholders”) entered into a Registration Rights Agreement under which the Securityholders have specified registration rights relating to the Stock Consideration. On January 20, 2026, we filed a Registration Statement on Form S-3ASR and a related prospectus supplement with the SEC, relating to the resale from time to time of up to 10,430,444 Common Shares by the Securityholders identified as selling stockholders in the prospectus supplement.

33


Transfer to The Nasdaq Stock Market LLC
In July 2026, we voluntarily transferred the listing and trading of our Common Shares from the New York Stock Exchange (the “NYSE”) to The Nasdaq Stock Market LLC (“Nasdaq”), retaining the ticker symbol “QBTS”. The listing and trading of our Common Shares on the NYSE ended as of market close on July 24, 2026 and trading of our Common Shares on Nasdaq began at market open on July 27, 2026.
U.S. Department of Commerce Award and Securities Issuance Agreement
As described in Note 14 - Stockholders' equity to the condensed consolidated financial statements, in September 2026, the Company entered into an arrangement with the U.S. Department of Commerce under which the Department agreed to provide up to $100.0 million of funding, in installments upon satisfying specified milestones and conditions, for the Company’s quantum computing research and development and received 7,095,721 shares of the Company’s common stock. The accounting treatment of this transaction is complex, and the Company voluntarily initiated a consultation with the SEC staff to seek confirmation that they do not disagree with the accounting treatment the Company has selected. As of the date of this filing, the consultation with the SEC staff has not been concluded. See Part II, Item 1A., “Risk Factors—Risk Factors Related to Our CHIPS Act Award” below.
Macroeconomic Environment
Unfavorable conditions in the economy in the United States, Canada and abroad, including conditions resulting from changes in inflationary pressure, gross domestic product growth, financial and credit market fluctuations, supply chain constraints, governmental actions and regulations such as international trade policies, tariffs and export controls, national security interests, political turmoil, natural catastrophes, outbreaks of contagious diseases, warfare and terrorist attacks in the United States, Europe or other parts of the world, including the continuing war in Ukraine, the war in Iran and resulting energy market disruptions and volatility in energy prices, and other conflicts in the Middle East, could cause a decrease in business investments in our products and services and negatively affect the growth of our business and our results of operations. While the impact of these macroeconomic conditions on our business, results of operations and financial position remains uncertain over the long term, to date, these unfavorable conditions have not affected our business.
Key Components of Results of Operations
Revenue
We currently generate our revenue through sales of quantum computer systems, subscription sales of our QCaaS service, professional services related to the development and implementation of quantum computing applications and delivery of quantum computing application development training.
Revenue from quantum computing system sales and system upgrade projects is generally recognized over time during the installation or upgrade period using an input method, with progress measured based on costs incurred to date relative to total estimated costs, a percentage-of-completion approach, as the criteria for over-time revenue recognition under ASC 606 are met. This approach is applied to system sales and upgrade projects that span multiple reporting periods and meet the criteria for over-time revenue recognition in accordance with ASC 606. From time to time, system sales may be recognized at a point in time if over time recognition is precluded. Both revenue from quantum computing system sales and revenue from system upgrade projects are classified within system sales in our financial statements. QCaaS revenue is recognized on a ratable basis over the contract term, which generally ranges from one quarter to multiple years. Professional services revenue, which includes QCaaS application development and paid research projects, is recognized over time on a percentage of completion basis using the costs incurred input measure of progress.
We expect revenue from system sales to become a larger component of our revenue mix. Because the timing of system installations and upgrades varies, and the related revenue is recognized over relatively short periods, our total revenue and revenue mix may fluctuate significantly from period to period, and period-over-period comparisons may not be indicative of future performance. We also expect QCaaS revenue to increase over time. Our professional services organization supports this growth by helping customers develop and deploy quantum applications, and we view professional services as a strategic enabler of long-term QCaaS adoption.
Cost of Revenue
Cost of revenue for quantum computing systems includes direct manufacturing costs, such as materials and labor for system production, as well as expenses related to installation, maintenance, and support. Additionally, it includes shipping and handling costs associated with delivering the systems. These costs are also expensed as incurred.

34


Cost of revenue also includes all direct and indirect expenses related to providing our QCaaS offering and delivering our professional services, such as personnel-related expenses, including stock-based compensation, costs associated with maintaining the Leap platform on which we provide the QCaaS service and depreciation and amortization related to our quantum computing systems and related software.

We expect our total cost of revenue to increase in absolute dollars over time, consistent with our anticipated revenue growth and the costs of supporting our customers, maintaining the Leap platform, manufacturing, installing and operating our quantum computing systems, and delivering our professional services. Because the timing of system installations and upgrades varies, our cost of revenue and gross margin may fluctuate from period to period depending on the relative contribution of system sales, QCaaS, and professional services to our revenue.
Operating Expenses
Our operating expenses consist of research and development, general and administrative, and sales and marketing expenses.
Research and Development
Research and development expenses consist primarily of personnel-related expenses, including salaries, benefits and stock-based compensation for personnel, fabrication costs, lab supplies, and cloud computing resources and allocated facility costs for our research and development functions. Research and development expenses also include purchased hardware components, fabrication and software costs related to quantum computing systems constructed for research purposes that do not have a high probability of providing near-term future economic benefits, and may have no alternate future use. We currently do not capitalize any research and development expenses.
We expect our research and development expenses will trend upward on an absolute dollar basis for the foreseeable future as we continue to invest in research and development efforts to enhance the performance of our annealing quantum computers, further develop our gate-model quantum computer, advance our superconducting bump bond process, upgrade our printed circuit board packaging manufacturing, and broaden the functionality and improve the reliability, availability and scalability of our Leap service. If in the future we receive government grants and research incentives, which have historically offset a portion of research and development costs, these costs could decrease in absolute dollars. Also, non-cash stock-based compensation expenses may cause upward and downward fluctuations in these costs from time to time.
General and Administrative
General and administrative expenses consist primarily of personnel-related expenses, including salaries, benefits and stock-based compensation for personnel and outside professional services expenses including legal, audit and accounting services, insurance, other administrative expenses and allocated facility costs for our administrative functions.
We expect our general and administrative expenses to increase in absolute dollars for the foreseeable future as we continue to invest in more comprehensive compliance and governance functions, increased IT security and compliance, and expanded internal controls over financial reporting in accordance with the Sarbanes-Oxley Act. However, non-cash stock-based compensation expenses may cause upward and downward fluctuations in these costs from time to time.
Sales and Marketing
Sales and marketing expenses consist primarily of personnel-related expenses, including salaries, benefits and stock-based compensation for personnel, direct advertising, marketing and promotional material costs, sales commission expense, consulting fees and allocated facility costs for our sales and marketing functions. We intend to continue to make significant investments in our sales and marketing organization to drive additional revenue, expand our global customer base, and broaden our brand awareness.
We expect our sales and marketing expenses to continue to increase in absolute dollars for the foreseeable future. However, non-cash stock-based compensation expenses may cause upward and downward fluctuations in these costs from time to time.

35


Results of Operations
Comparison of the Three Months Ended September 30, 2026 and 2025
Three Months Ended September 30,Variance
(In thousands, except share and per share data)20262025Amount%
Revenue$4,513 $3,739 $774 21 %
Cost of revenue2,127 1,070 1,057 99 %
Total gross profit2,386 2,669 (283)(11)%
Operating expenses:
Research and development31,543 14,075 17,468 124 %
General and administrative13,100 9,383 3,717 40 %
Sales and marketing11,225 6,947 4,278 62 %
Total operating expenses55,868 30,405 25,463 84 %
Loss from operations(53,482)(27,736)(25,746)93 %
Other income (expense), net:
Interest income4,864 8,581 (3,717)(43)%
Interest expense(350)(201)(149)74 %
Gain on investment in marketable securities, net882 850 32 4 %
Change in fair value of warrant liabilities— (121,859)121,859 (100)%
Other income (expense), net(179)379 (558)(147)%
Total other income (expense), net5,217 (112,250)117,467 (105)%
Loss before income taxes(48,265)(139,986)91,721 (66)%
Income tax benefit (provision), net68 — 68 n/a
Net loss(48,197)(139,986)91,789 (66)%
Revenue
Revenue increased to $4.5 million for the three months ended September 30, 2026 as compared to $3.7 million for the three months ended September 30, 2025. Professional services increased by $1.5 million, and QCaaS revenue increased by $0.8 million offset by a decrease in system sales revenue of $1.5 million.
Cost of Revenue
Cost of revenue increased by $1.0 million, or 99%, to $2.1 million for the three months ended September 30, 2026 as compared to $1.1 million for the three months ended September 30, 2025. The increase in cost of revenue was primarily due to an increase in personnel costs of $0.9 million driven by more paid research projects, and an increase in stock-based compensation costs of $0.2 million.
Operating Expenses
Research and Development Expenses
Research and development expenses increased by $17.4 million, or 124%, to $31.5 million for the three months ended September 30, 2026 compared to $14.1 million for the three months ended September 30, 2025. The increase was primarily driven by increases in personnel costs of $8.5 million, depreciation and amortization expense of $4.2 million and stock-based compensation expense of $2.8 million.
General and Administrative Expenses
General and administrative expenses increased by $3.7 million, or 40%, to $13.1 million for the three months ended September 30, 2026 as compared to $9.4 million for the three months ended September 30, 2025. The increase was primarily driven by increases in personnel expenses of $1.7 million, stock-based compensation expense of $0.6 million, and software costs of $0.7 million.

36


Sales and Marketing Expenses
Sales and marketing expenses increased by $4.3 million, or 62%, to $11.2 million for the three months ended September 30, 2026 as compared to $6.9 million for the three months ended September 30, 2025. The increase was primarily driven by increases in personnel costs of $2.1 million, marketing expenses of $1.0 million and stock-based compensation expense of $0.7 million.
Other Income (Expense), net
Interest income
Interest income decreased by $3.7 million, or 43%, to $4.9 million for the three months ended September 30, 2026 as compared to $8.6 million for the three months ended September 30, 2025. The decrease was driven primarily by lower cash and investment balances.
Interest Expense
Interest expense increased modestly to $0.4 million for the three months ended September 30, 2026 as compared to $0.2 million for the three months ended September 30, 2025.
Gain on investment in marketable securities, net
Gain on investment in marketable securities was $0.9 million for each of the three months ended September 30, 2026 and three months ended September 30, 2025.
Change in fair value of warrant liabilities
The change in fair value of warrant liabilities was zero for the three months ended September 30, 2026 as compared to $121.9 million for the three months ended September 30, 2025. The Company had no Public Warrants outstanding following the redemption of all remaining warrants on November 19, 2025 pursuant to the Warrant Agreement.
Other income (expense), net
Other income (expense), net decreased by $0.6 million or 147%, to a net other expense of $0.2 million for the three months ended September 30, 2026 as compared to a net other income of $0.4 million for the three months ended September 30, 2025. The decrease was primarily driven by the impact of net foreign exchange movements.

37


Comparison of the Nine Months Ended September 30, 2026 and 2025
The following table sets forth our results of operations for the periods indicated (in thousands):
Nine Months Ended September 30,Variance
(In thousands, except share and per share data)20262025Amount%
Revenue$10,447 $21,835 $(11,388)(52)%
Cost of revenue4,539 3,313 1,226 37 %
Total gross profit5,908 18,522 (12,614)(68)%
Operating expenses:
Research and development85,575 37,057 48,518 131 %
General and administrative48,763 26,491 22,272 84 %
Sales and marketing33,057 20,503 12,554 61 %
Total operating expenses167,395 84,051 83,344 99 %
Loss from operations(161,487)(65,529)(95,958)146 %
Other income (expense), net:
Interest income15,677 15,991 (314)(2)%
Interest expense(864)(633)(231)36 %
Gain on investment in marketable securities, net2,762 850 1,912 225 %
Change in fair value of warrant liabilities— (259,964)259,964 (100)%
Other income (expense), net818 (3,451)4,269 124 %
Total other income (expense), net18,393 (247,207)265,600 (107)%
Loss before income taxes(143,094)(312,736)169,642 (54)%
Income tax benefit (provision), net28,512 — 28,512 n/a
Net loss(114,582)(312,736)198,154 (63)%
Foreign currency translation adjustment153 1,384 (1,231)(89)%
Unrealized losses on available-for-sale securities(195)— (195)n/a
Reclassification adjustment for realized gains (losses) included in net income(16)— (16)n/a
Net comprehensive loss$(114,640)$(311,352)$196,712 (63)%
Revenue
Revenue for the nine months ended September 30, 2026 was $10.4 million, a decrease of $11.4 million, or 52%, from revenue of $21.8 million for the nine months ended September 30, 2025. The decrease was primarily driven by a decrease in system sales of $14.8 million, reflecting revenue recognized in the prior year period upon the installation and processor upgrade of a sold system, partially offset by an increase in QCaaS revenue of $1.6 million and an increase in professional services revenue of $1.9 million.
Cost of Revenue
Cost of revenue increased by $1.2 million, or 37%, to $4.5 million for the nine months ended September 30, 2026 as compared to $3.3 million for the nine months ended September 30, 2025. The increase in cost of revenue was primarily due to an increase in personnel-related costs driven by more paid research projects.
Operating Expenses
Research and Development Expenses
Research and development expenses increased by $48.5 million, or 131%, to $85.6 million for the nine months ended September 30, 2026 compared to $37.1 million for the nine months ended September 30, 2025. The increase was primarily driven by increases in personnel costs of $19.7 million, depreciation and amortization of $11.6 million and stock-based compensation expense of $8.8 million.
General and Administrative Expenses
General and administrative expenses increased by $22.3 million, or 84%, to $48.8 million for the nine months ended September 30, 2026 as compared to $26.5 million for the nine months ended September 30, 2025. The increase was primarily driven by an increase in professional fees of $7.2 million (largely comprised of transaction expenses from the Acquisition), an increase in personnel expenses of $6.1 million and acquisition-related insurance expenses of $2.0 million.

38


Sales and Marketing Expenses
Sales and marketing expenses increased by $12.6 million, or 61%, to $33.1 million for the nine months ended September 30, 2026 as compared to $20.5 million for the nine months ended September 30, 2025. The increase was primarily driven by increases in personnel costs of $5.7 million, marketing expenses of $3.2 million, and stock-based compensation expense of $2.0 million.
Other Income (Expense), net
Interest income
Interest income decreased by $0.3 million, to $15.7 million for the nine months ended September 30, 2026 as compared to $16.0 million for the nine months ended September 30, 2025. The decrease was driven primarily by a lower cash and cash equivalent balances and the Company’s investment in short-term government debt.
Interest expense
Interest expense increased modestly to $0.9 million for the nine months ended September 30, 2026 as compared to $0.6 million for the nine months ended September 30, 2025.
Gain on investment in marketable securities, net
Gain on investment in marketable securities, net was a gain of $2.8 million for the nine months ended September 30, 2026 as compared to $0.9 million for the nine months ended September 30, 2025. The gain in the current period was attributable to an observable price change resulting from a third-party transaction involving the Company’s investment in a privately-held company. Accordingly, the carrying value of the investment was adjusted based on the transaction price, resulting in a net gain.
Change in fair value of warrant liabilities
The change in fair value of warrant liabilities was zero for the nine months ended September 30, 2026 as compared to a decrease of $260.0 million for the nine months ended September 30, 2025. The fair value of the warrant liabilities varied primarily with the trading price of the Public Warrants, which were listed on the NYSE. The trading price of the Public Warrants decreased during the nine months ended September 30, 2025, generally in line with the decline in the trading price of the Common Shares, resulting in a corresponding decrease in the fair value of the warrant liabilities. The Company had no Public Warrants outstanding following the redemption of all remaining warrants on November 19, 2025 pursuant to the Warrant Agreement.
Other income (expense), net
Other income (expense), net increased by $4.3 million or 124%, to a net other income of $0.8 million for the nine months ended September 30, 2026 as compared to a net other expense of $3.5 million for the nine months ended September 30, 2025. The increase was primarily driven by the impact of net foreign exchange movements in the prior period of $4.2 million resulting from appreciation of the U.S. Dollar against certain foreign currencies.
Income tax benefit (provision), net
Income tax benefit (provision), net was $28.5 million for the nine months ended September 30, 2026 as compared to zero for the nine months ended September 30, 2025. The increase was primarily driven by deferred tax liabilities assumed in connection with the Quantum Circuits acquisition. The deferred tax liabilities provided an additional source of taxable income required to utilize existing deferred tax assets, which resulted in the partial release of the valuation allowance against the deferred tax assets.
Liquidity and Capital Resources
The Company has historically raised capital through equity issuances, including at-the-market (“ATM”) offerings, an Equity Line of Credit (“ELOC” or “Lincoln Park Purchase Agreement”) with Lincoln Park Capital Fund, and warrant exercises.
As of December 31, 2025, the Company had completed all issuances under its prior equity programs, including the ELOC and its ATM sales agreements. During the year ended December 31, 2025, the Company received significant net proceeds from these programs, as well as from warrant exercises, which strengthened its liquidity position.
The Company has no Public Warrants outstanding during 2026 following the redemption of all remaining warrants in November 2025 pursuant to the Warrant Agreement.

39


The Company entered into the Equipment Financing Agreement in August 2025, which provides a conditional commitment of up to $13.8 million to finance certain capital equipment purchases. Refer to Note 9 - Loans payable, net to the condensed consolidated financial statements for additional information.
As described in Note 14 - Stockholders' equity to the condensed consolidated financial statements, in September 2026, the Company entered into an arrangement with the U.S. Department of Commerce under which the Department agreed to provide up to $100.0 million of staged funding for the Company’s quantum computing research and development and received 7,095,721 shares of the Company’s common stock. Of the total, $53.6 million became available at September 4, 2026, which is referred to in the agreement as the “Award Date”; the remaining $46.4 million is subject to milestone achievement determinations made by the Department in its sole discretion, and there can be no assurance as to the timing or amount of any future availability. Funds drawn from the Award Date tranche or a subsequent tranche must be applied to eligible project costs within 30 days or returned. As of September 30, 2026, the Company had not received any funds from the Award.
Cash Flows
The following table sets forth our cash flows for the periods indicated (in thousands):
Nine Months Ended September 30,
20262025
Net cash provided by (used in):
Operating Activities$(109,025)$(53,610)
Investing Activities(241,894)(1,567)
Financing Activities(5,199)712,044 
Effect of exchange rate changes on cash and cash equivalents137 1,384 
Net increase (decrease) in cash and cash equivalents$(355,981)$658,251 
Cash Flows Used in Operating Activities
Our cash flows from operating activities are significantly affected by the growth of our business, and are primarily related to research and development, sales and marketing and general and administrative activities. Our operating cash flows are also affected by our working capital needs and fluctuations in our working capital balances.
For the nine months ended September 30, 2026, net cash used in operating activities was $109.0 million, an increase of $55.4 million from $53.6 million for the nine months ended September 30, 2025. The change is primarily due to a decrease in net loss of $198.2 million, offset by an increase in cash released from working capital of $13.8 million (primarily related to the recognition of deferred revenue) and a decrease in noncash items added back to net loss of $267.4 million (primarily related to decreased non-cash charges related to remeasurement of the warrant liability, offset by increased non-cash deferred tax benefits).
Cash Flows Used in Investing Activities
Net cash used in investing activities during the nine months ended September 30, 2026 was $241.9 million, an increase of $240.3 million from $1.6 million for the nine months ended September 30, 2025. The increase primarily reflects cash consideration for the Acquisition of $252.8 million during the nine months ended September 30, 2026. There was no similar activity during the nine months ended September 30, 2025.
Cash Flows Provided by Financing Activities
Net cash used by financing activities during the nine months ended September 30, 2026 was $5.2 million, as compared to net cash provided by financing activities of $712.0 million for the nine months ended September 30, 2025. The change is primarily due to a decrease in proceeds from the issuance of Common Shares pursuant to equity offerings of $574.5 million, and a decrease in proceeds from warrant exercises of $139.2 million.

40


Contractual Obligations and Commitments
As of September 30, 2026, there have been no material changes with regard to contractual obligations from those disclosed in our “Management's Discussion and Analysis on Financial Condition and Results of Operations—Contractual Obligations and Commitments” in our Annual Report on Form 10-K for the year ended December 31, 2025.
Critical Accounting Estimates
There have been no material changes to our critical accounting policies from those disclosed in our “Management's Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2025.
Recently Issued and Adopted Accounting Standards
A discussion of recent accounting pronouncements is included in Note 2 - Basis of Presentation and Summary of Significant Accounting Policies to our unaudited consolidated financial statements included elsewhere in this Report.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to financial market risks, including changes in foreign currency exchange rates and interest rates.
Foreign Currency Exchange Risk
We transact business globally in multiple currencies. International revenues and foreign-denominated monetary assets and liabilities expose us to the risk of fluctuations in foreign exchange rates against the U.S. dollar. Our principal currency exposure is to the Canadian dollar, with smaller exposures to the British pound, Euro, and Japanese yen. Considering historical trends in foreign exchange rates, we determined that it was reasonably possible that adverse changes in exchange rates of 10% could be experienced. We performed a sensitivity analysis on our foreign currency exposures to estimate the potential impact of this adverse 10% change. The estimated effects on our financial position would be as follows (in thousands):
ImpactAs of September 30, 2026
Foreign denominated monetary assets and liabilitiesOI&E $(4,390)
Interest Rate Risk
We had cash, cash equivalents, and short-term investments of $503.4 million as of September 30, 2026. We hold our cash and cash equivalents for working capital and general corporate purposes. Our cash and cash equivalents are held in cash and checking deposits, money market funds, and government securities. Our investments are held in short-term government securities. The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increased risk. To achieve this objective, we invest in highly liquid securities depending on our strategic cash needs. Due to the nature of these instruments, we believe that we do not have any material exposure to changes in the fair value due to changes in interest rates. Declines in interest rates, however, would reduce our future interest income. Further, in the event of a significant decline in interest rates, we would consider taking actions to mitigate our exposure to the change.
Item 4. Controls and Procedures
Limitations on Effectiveness of Controls and Procedures
In designing and evaluating our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

41


Disclosure Controls and Procedures
We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (2) accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Our management, with the participation of our Chief Executive Officer and Acting Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Report. Based on such evaluation, our Chief Executive Officer and Acting Chief Financial Officer have concluded that as of September 30, 2026, our disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Control Over Financial Reporting
There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act), during the three months ended September 30, 2026 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

42


Part II - Other Information
Item 1. Legal Proceedings
From time to time, we may become involved in legal proceedings arising in the ordinary course of business.
On October 15, 2026, a putative stockholder class action was filed in the United States District Court for the Northern District of California against the Company and certain current and former members of our senior management, captioned Fessler v. D-Wave Quantum Inc., et al. (Case No. 3:26-cv-11953). On October 20, 2026, another action was filed in the same court captioned Lawrence v. D-Wave Quantum Inc., et al. (Case No. 3:26-cv-12155). Each action (together, the “Actions”) asserts claims under Sections 10(b) and 20(a) of the Exchange Act, alleging that the Company and certain of its current and former officers made materially false or misleading statements, including about the Company’s operational and financial performance and growth. The plaintiffs in the Actions seek unspecified monetary damages and an award of costs and expenses, including reasonable attorneys’ fees and expert fees. We believe these claims are without merit, and we intend to defend the matters vigorously.
On November 2, 2026, a stockholder, Christopher Crull, filed a derivative lawsuit in the United States District Court for the Northern District of California, Crull v. Baratz, et al. (Case No. 5:26-cv-13006), against the Company (as nominal defendant only) and certain of the Company’s current and former directors and officers for, among other things, breach of fiduciary duty. The complaint alleges that the named directors and officers issued or caused the Company to issue materially false or misleading statements, including about the Company’s performance and growth and the Company’s internal controls, and that the Company suffered damages as a result. The complaint seeks, among other things, unspecified damages and reforms to the Company’s corporate governance and internal procedures.
The ultimate outcome of any litigation is uncertain and unfavorable outcomes could have a negative impact on our results of operations and financial condition. Defending such proceedings is costly and can impose a significant burden on management and team members. The results of litigation cannot be predicted with certainty, but regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
As we are unable to determine at this time whether any loss ultimately will occur or to estimate the range of such loss, no amount of loss has been accrued by us in our financial statements as of and for the three and nine months ended September 30, 2026. If the potential loss from any claim or legal proceeding is considered probable and the amount is reasonably estimable, we will accrue a liability for the estimated loss. Legal proceedings are inherently uncertain and as circumstances change, it is possible that the amount of any accrued liability may increase, decrease or be eliminated.
There are currently no other pending or, to our knowledge, threatened legal proceedings or claims against us that, in our opinion, are likely to have a material adverse effect on our business, operating results, financial condition or cash flows.

43


Item 1A. Risk Factors
Except as set forth below, there have been no material changes from the risk factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on February 26, 2026 (the “2025 Form 10-K”):
Risk Factor Relating to Securities Litigation
The following risk factor in our 2025 Form 10-K is amended and restated in its entirety to read as follows:
We are, and may in the future be, subject to securities litigation, which is expensive and could divert management attention.
Companies that have experienced volatility in the market price of their stock have been subject to securities litigation, including class action litigation. In October 2026, two actions were filed against us and certain current and former members of our senior management in the United States District Court for the Northern District of California, asserting claims under Sections 10(b) and 20(a) of the Exchange Act and alleging that we and certain of our current and former officers made materially false or misleading statements, including about our operational and financial performance and growth. In November 2026, a derivative suit was filed in the same court against us and certain current and former directors and officers, alleging that the named directors and officers issued or caused the Company to issue materially false or misleading statements, including about our performance and growth and our internal controls, and that the Company suffered as a result. See Part II, Item 1, “Legal Proceedings.” We may be subject to additional securities class actions, shareholder derivative suits or other claims relating to the matters alleged or otherwise. Such litigation, regardless of its merit or outcome, could result in substantial costs and diversion of management’s attention and resources, which could have a material adverse effect on our business, financial condition, and results of operations. Any adverse determination in litigation could also subject us to significant liabilities.
Risk Factors Related to Our CHIPS Act Award
The execution of the OTA and the SIA with the Department, the receipt of funding thereunder and the Department’s ownership of an equity interest in the Company may subject the Company and its stockholders to a number of risks and uncertainties.
•The timing and amount of funding under the OTA remain uncertain. The Company’s receipt of Award funds is subject to the terms and conditions of the OTA, and there can be no assurance that the Company will receive the anticipated funds on the expected timeline, in the anticipated amounts, or at all. The Company’s receipt of funds also depends on the continued availability of appropriations from the U.S. government and the willingness and ability of the executive branch to provide the funding and support contemplated by the transactions.
•The transactions are subject to risks from changes in laws, regulations, or their interpretation, as well as shifts in federal administration and policy priorities. The legislative, judicial or executive branches of the U.S. government could determine in the future that all or a portion of the transactions were unauthorized, void or voidable. No agency or branch of the U.S. government other than the Department has made any commitment to support, or refrain from challenging, the transactions. Legal challenges, administrative rulings, litigation or geopolitical developments could materially impair funding, alter the Company’s obligations under the OTA, or otherwise adversely affect the anticipated benefits of the transactions and enforcement against a government counterparty is inherently uncertain given the defenses available to the U.S. government.
•The transactions are dilutive to existing stockholders. The issuance of the Shares to the Department at a discount to the market price of the Company’s common stock on the Award Date is dilutive to existing stockholders.
•The Department’s equity position in the Company may limit potential future strategic transactions. Although the SIA restricts the Department’s ability to vote the Shares except with respect to certain specified matters, the existence of a U.S. government equity interest, together with the Department’s contractual rights, including registration rights, may limit the Company’s ability to pursue potential future strategic transactions that could be beneficial to stockholders, including by limiting the willingness of third parties to engage in such transactions with the Company.

44


•The financial, tax and accounting treatment of the transactions is uncertain. Given the novelty and complexity of the OTA and the SIA, and the limited precedent for the accounting treatment for our transactions with the Department, the Company’s analysis of the financial, tax and accounting implications of its commitments and obligations thereunder has required the exercise of significant judgment in determining the appropriate accounting treatment. While we believe we have selected an appropriate accounting approach for these transactions in our Consolidated Condensed Financial Statements in this Form 10-Q, there are other potential approaches that, if applied, would result in materially different financial results for our third quarter of 2026 and could also materially and adversely impact our results for future periods. Refer to Note 2—“Basis of Presentation and Summary of Significant Accounting Policies—U.S. Department of Commerce Award and Securities Issuance Agreement” and Note 14—“Stockholders’ Equity—U.S. Department of Commerce Award and Securities Issuance Agreement” within the Notes to Condensed Consolidated Financial Statements for additional information. We recently voluntarily initiated a consultation with the SEC staff to seek confirmation that they do not disagree with the accounting treatment we have selected; however, this consultation has not been concluded as of the date of this filing. If the SEC staff have a different view of the appropriate accounting treatment, we may be required to materially revise our third quarter 2026 financial results, including the recognition of additional costs or losses, and our results for future periods may also be materially and adversely impacted.
•The Company may experience other adverse consequences resulting from the announcement or completion of the transactions. Given the limited number of precedents for transactions of this type involving the U.S. government taking an equity position in a company such as the Company, it is difficult to foresee all potential consequences. These may include adverse reactions from investors, employees, customers, suppliers or other business or commercial partners, as well as increased public or political scrutiny of the Company, and there may also be litigation relating to the transactions.
Any of the foregoing could have a material adverse effect on the Company’s revenue, operations, financial position, cash flows, access to financing, cost structure, competitiveness, reputation, profitability and prospects, and could exacerbate other risks discussed in the Company’s 2025 Form 10-K, Q1 2026 Form 10-Q and Q2 2026 Form 10-Q.
Risk Factor Relating to the Transfer of Our Stock Exchange Listing to Nasdaq
The following risk factor in our 2025 Form 10-K is amended and restated in its entirety to read as follows:
If we are unable for any reason to meet the continued listing requirements of Nasdaq, such action or inaction could result in a delisting of our Common Shares.
From August 5, 2022 through July 24, 2026, our Common Shares were listed on the NYSE. In July 2026, we voluntarily transferred the listing and trading of our Common Shares from the NYSE to Nasdaq, retaining the ticker symbol “QBTS”. The listing and trading of our Common Shares on the NYSE ended as of market close on July 24, 2026 and trading of our Common Shares on Nasdaq began at market open on July 27, 2026.
We were notified by the NYSE on three occasions, most recently in October 2024, that we were not in compliance with the NYSE's continued listing requirements because the average closing price of our Common Shares was less than $1.00 over a consecutive 30 trading-day period. Such notices had no immediate impact on the listing of our Common Shares, which continued to be listed and traded on the NYSE and on each occasion we regained compliance with the NYSE listing requirements during the period allowed to regain compliance.
Following the transfer of the listing of our Common Shares to Nasdaq, we are subject to similar Nasdaq continued listing requirements. If we cannot remain in compliance with the Nasdaq listing requirements, or cannot regain compliance if we become non-compliant in the future, our Common Shares will be delisted from Nasdaq. The delisting of our Common Shares from Nasdaq would likely make it more difficult for us to raise capital on favorable terms in the future, would likely have a negative effect on the price of our securities and would impair our stockholders' ability to sell or purchase our securities when they wish to do so. In the event of a delisting, actions taken by us to restore compliance with listing requirements may not allow our securities to become listed again, stabilize the market price or improve the liquidity of our securities, prevent such securities from dropping below any minimum bid price requirement or prevent future non-compliance with the Nasdaq listing requirements.


45


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On September 8, 2026, we issued 7,095,721 Common Shares to the Department pursuant to the SIA at an aggregate price of $100.0 million, $53.6 million of which became eligible for payment as of the Award Date pursuant to the terms of the OTA and the remainder of which amount will be paid as the milestones in the OTA are achieved. The issuance of the Shares was made in reliance upon an exemption from registration under the Securities Act, pursuant to Section 4(a)(2) thereof for transactions by an issuer not involving any public offering.
Item 3. Defaults Upon Senior Securities
None.

46


Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
Securities Trading Plans of Directors and Executive Officers
From time to time, some of the Company’s directors or executive officers may determine that it is advisable to diversify their investments for personal financial planning reasons or may seek liquidity for other reasons and may sell Common Shares. To effect such sales, from time to time, some of the Company’s directors or executive officers may enter into trading plans that are designed to comply with the Company’s Amended and Restated Securities Trading Policy and intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act.
During the three months ended September 30, 2026, the following executive officer of the Company adopted a “Rule 10b5-1 trading arrangement,” as such term is defined under Item 408 of Regulation S-K:
Name and Title of Director or Executive OfficerDate of Adoption
Expiration Date of Trading Arrangement1
Aggregate Number of Securities to be Sold
Sophie Ames, Executive Vice President & Chief Human Resources Officer
August 19, 2026November 18, 2027
Up to 311,564 Common Shares
1 The trading arrangement may end earlier if all transactions under the trading arrangement are completed prior to the expiration date.
During the three months ended September 30, 2026, none of the Company's directors or other executive officers adopted a “Rule 10b5-1 trading arrangement,” and none of the Company’s directors or executive officers modified or terminated a “Rule 10b5-1 trading arrangement” or adopted, modified, or terminated a “non-Rule 10b5-1 trading arrangement,” as such terms are defined under Item 408 of Regulation S-K.

47


Item 6. Exhibits
Exhibit No.
Description
Incorporated by Reference Exhibits
Filer
Form
Exhibit
Filing Date
10.1+
Other Transaction Agreement, dated September 4, 2026 by and between D-Wave Quantum Inc. and the United States Department of Commerce.
D-Wave Quantum Inc.8-K10.1September 8, 2026
10.2+
Securities Issuance Agreement, dated September 8, 2026 by and between D-Wave Quantum Inc. and the United States Department of Commerce.
D-Wave Quantum Inc.8-K/A10.2September 9, 2026
10.3*#†
Full-Time Employment Agreement, dated April 24, 2023, between D-Wave Commercial Inc. and Greg Golkov.
10.4#
Offer Letter, dated September 17, 2026, between D-Wave Quantum Inc. and Greg Golkov.
D-Wave Quantum Inc.8-K/A10.1September 22, 2026
10.5*+
Technology as a Service Agreement, entered into effective as of October 10, 2026, by and between SkyWater Technology Foundry, Inc. and D-Wave Systems Inc.
31.1*
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.
31.2*
Certification of Acting Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.
32.1**
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**
Certification of Acting Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*
Inline XBRL Instance Document.
101.SCH*
Inline XBRL Taxonomy Extension Schema Document.
101.CAL*
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*
Inline XBRL Taxonomy Extension Labels Linkbase Document.
101.PRE*
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
*    Filed herewith.
**    Furnished with this report in accordance with Item 601(b)(32) of Regulation S-K, this exhibit is not deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. Such certifications will not be deemed incorporated by reference into any filing under the Securities Act, except to the extent that the registrant specifically incorporates it by reference.
#    Indicates management contract or compensatory plan or arrangement.
+    Certain portions of this exhibit (indicated by “[*****]”) have been redacted pursuant to Regulation S-K, Item 601(a)(5).
†    Certain portions of this exhibit (indicated by “[*****]”) have been redacted pursuant to Regulation S-K, Item 601(a)(6).




Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

D-Wave Quantum Inc.
November 16, 2026
By:
/s/ Gregory Golkov
Gregory Golkov
Acting Chief Financial Officer and Senior Vice President, Finance
(Principal Financial and Accounting Officer and Duly Authorized Officer)








Keep reading